BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG , ,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mous
|
|
|
- ふさこ くぬぎ
- 7 years ago
- Views:
Transcription
1 Bio X Cell 社価格表 (2018 年 4 月 ) < 株式会社シン コーポレーション > Bio X Cell 社価格表 (2018 年 4 月 ) ご注文ごとに別途取扱手数料 (2( 万円 税別 ) を申し受けます 大学向け価格でのご購入には アカデミックプライス適用申込書のご提出が必須となります 品番クローン品名イソタイプ 容量 (mg) 大学向希望小売価格 ( 円 ) 税別 希望小売価格 ( 円 ) 税別 InVivoMAb シリーズ BE G11 InVivoMab anti-mouse CD1d (CD1.1) rat IgG2b 1 15,000 22,000 BE G11 InVivoMab anti-mouse CD1d (CD1.1) rat IgG2b 5 55,000 77,000 BE G11 InVivoMab anti-mouse CD1d (CD1.1) rat IgG2b , ,000 BE G11 InVivoMab anti-mouse CD1d (CD1.1) rat IgG2b , ,000 BE G11 InVivoMab anti-mouse CD1d (CD1.1) rat IgG2b , ,000 BE C11 InVivoMab anti-mouse CD3ε Armenian hamster IgG 1 15,000 22,000 BE C11 InVivoMab anti-mouse CD3ε Armenian hamster IgG 5 55,000 77,000 BE C11 InVivoMab anti-mouse CD3ε Armenian hamster IgG , ,000 BE C11 InVivoMab anti-mouse CD3ε Armenian hamster IgG , ,000 BE C11 InVivoMab anti-mouse CD3ε Armenian hamster IgG , , C11 f(ab')2 BE0001-1FAB Fragments InVivoMab anti-mouse CD3ε F(ab')2 fragment hamster IgG2b 5 78, , C11 f(ab')2 BE0001-1FAB Fragments InVivoMab anti-mouse CD3ε F(ab')2 fragment hamster IgG2b , , C11 f(ab')2 BE0001-1FAB Fragments InVivoMab anti-mouse CD3ε F(ab')2 fragment hamster IgG2b , , C11 f(ab')2 BE0001-1FAB Fragments InVivoMab anti-mouse CD3ε F(ab')2 fragment hamster IgG2b , ,000 BE OKT-3 InVivoMab anti-human CD3 mouse IgG2a 1 15,000 22,000 BE OKT-3 InVivoMab anti-human CD3 mouse IgG2a 5 55,000 77,000 BE OKT-3 InVivoMab anti-human CD3 mouse IgG2a , ,000 BE OKT-3 InVivoMab anti-human CD3 mouse IgG2a , ,000 BE OKT-3 InVivoMab anti-human CD3 mouse IgG2a , ,000 BE A2 InVivoMab anti-mouse CD3 rat IgG2b 1 15,000 22,000 BE A2 InVivoMab anti-mouse CD3 rat IgG2b 5 55,000 77,000 BE A2 InVivoMab anti-mouse CD3 rat IgG2b , ,000 BE A2 InVivoMab anti-mouse CD3 rat IgG2b , ,000 BE A2 InVivoMab anti-mouse CD3 rat IgG2b , ,000 BE GK1.5 InVivoMab anti-mouse CD4 rat IgG2b 1 15,000 22,000 BE GK1.5 InVivoMab anti-mouse CD4 rat IgG2b 5 55,000 77,000 BE GK1.5 InVivoMab anti-mouse CD4 rat IgG2b , ,000 BE GK1.5 InVivoMab anti-mouse CD4 rat IgG2b , ,000 BE GK1.5 InVivoMab anti-mouse CD4 rat IgG2b , ,000 BE OKT-4 InVivoMab anti-human CD4 mouse IgG2b 1 15,000 22,000 BE OKT-4 InVivoMab anti-human CD4 mouse IgG2b 5 55,000 77,000 BE OKT-4 InVivoMab anti-human CD4 mouse IgG2b , ,000 BE OKT-4 InVivoMab anti-human CD4 mouse IgG2b , ,000 BE OKT-4 InVivoMab anti-human CD4 mouse IgG2b , ,000 BE YTS 177 InVivoMab anti-mouse CD4 rat IgG2a 1 15,000 22,000 BE YTS 177 InVivoMab anti-mouse CD4 rat IgG2a 5 55,000 77,000 BE YTS 177 InVivoMab anti-mouse CD4 rat IgG2a , ,000 BE YTS 177 InVivoMab anti-mouse CD4 rat IgG2a , ,000 BE YTS 177 InVivoMab anti-mouse CD4 rat IgG2a , ,000 BE InVivoMab anti-mouse CD8α rat IgG2a 1 15,000 22,000 BE InVivoMab anti-mouse CD8α rat IgG2a 5 55,000 77,000 BE InVivoMab anti-mouse CD8α rat IgG2a , ,000 BE InVivoMab anti-mouse CD8α rat IgG2a , ,000 BE InVivoMab anti-mouse CD8α rat IgG2a , ,000 BE OKT-8 InVivoMab anti-human CD8α mouse IgG2a 1 15,000 22,000 BE OKT-8 InVivoMab anti-human CD8α mouse IgG2a 5 55,000 77,000 BE OKT-8 InVivoMab anti-human CD8α mouse IgG2a , ,000 BE OKT-8 InVivoMab anti-human CD8α mouse IgG2a , ,000 BE OKT-8 InVivoMab anti-human CD8α mouse IgG2a , ,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG1 1 15,000 22,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG1 5 55,000 77,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG , ,000 1 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
2 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG , ,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG , ,000 BE FD441.8 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2b 1 15,000 22,000 BE FD441.8 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2b 5 55,000 77,000 BE FD441.8 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2b , ,000 BE FD441.8 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2b , ,000 BE FD441.8 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2b , ,000 BE0006 M17/4 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2a 1 15,000 22,000 BE0006 M17/4 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2a 5 55,000 77,000 BE0006 M17/4 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2a , ,000 BE0006 M17/4 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2a , ,000 BE0006 M17/4 InVivoMab anti-mouse LFA-1α (CD11a) rat IgG2a , ,000 BE0007 M1/70 InVivoMab anti-mouse/human CD11b rat IgG2b 1 15,000 22,000 BE0007 M1/70 InVivoMab anti-mouse/human CD11b rat IgG2b 5 55,000 77,000 BE0007 M1/70 InVivoMab anti-mouse/human CD11b rat IgG2b , ,000 BE0007 M1/70 InVivoMab anti-mouse/human CD11b rat IgG2b , ,000 BE0007 M1/70 InVivoMab anti-mouse/human CD11b rat IgG2b , ,000 BE0009 M18/2 InVivoMab anti-mouse CD18 rat IgG2a 1 15,000 22,000 BE0009 M18/2 InVivoMab anti-mouse CD18 rat IgG2a 5 55,000 77,000 BE0009 M18/2 InVivoMab anti-mouse CD18 rat IgG2a , ,000 BE0009 M18/2 InVivoMab anti-mouse CD18 rat IgG2a , ,000 BE0009 M18/2 InVivoMab anti-mouse CD18 rat IgG2a , ,000 BE0011 Cy34.1 InVivoMab anti-mouse CD22 mouse IgG1 1 15,000 22,000 BE0011 Cy34.1 InVivoMab anti-mouse CD22 mouse IgG1 5 55,000 77,000 BE0011 Cy34.1 InVivoMab anti-mouse CD22 mouse IgG , ,000 BE0011 Cy34.1 InVivoMab anti-mouse CD22 mouse IgG , ,000 BE0011 Cy34.1 InVivoMab anti-mouse CD22 mouse IgG , ,000 BE0012 PC InVivoMab anti-mouse CD25 (IL-2Rα) rat IgG1 1 15,000 22,000 BE0012 PC InVivoMab anti-mouse CD25 (IL-2Rα) rat IgG1 5 55,000 77,000 BE0012 PC InVivoMab anti-mouse CD25 (IL-2Rα) rat IgG , ,000 BE0012 PC InVivoMab anti-mouse CD25 (IL-2Rα) rat IgG , ,000 BE0012 PC InVivoMab anti-mouse CD25 (IL-2Rα) rat IgG , ,000 BE0013 7D4 InVivoMab anti-mouse CD25 (IL-2Rα) rat IgM 1 15,000 22,000 BE0013 7D4 InVivoMab anti-mouse CD25 (IL-2Rα) rat IgM 5 55,000 77,000 BE0013 7D4 InVivoMab anti-mouse CD25 (IL-2Rα) rat IgM , ,000 BE0013 7D4 InVivoMab anti-mouse CD25 (IL-2Rα) rat IgM , ,000 BE0013 7D4 InVivoMab anti-mouse CD25 (IL-2Rα) rat IgM , ,000 BE0014 7G7B6 InVivoMab anti-human CD25 (IL-2Rα) mouse IgG2a 1 15,000 22,000 BE0014 7G7B6 InVivoMab anti-human CD25 (IL-2Rα) mouse IgG2a 5 55,000 77,000 BE0014 7G7B6 InVivoMab anti-human CD25 (IL-2Rα) mouse IgG2a , ,000 BE0014 7G7B6 InVivoMab anti-human CD25 (IL-2Rα) mouse IgG2a , ,000 BE0014 7G7B6 InVivoMab anti-human CD25 (IL-2Rα) mouse IgG2a , ,000 BE InVivoMab anti-mouse CD28 Syrian hamster IgG2 1 15,000 22,000 BE InVivoMab anti-mouse CD28 Syrian hamster IgG2 5 55,000 77,000 BE InVivoMab anti-mouse CD28 Syrian hamster IgG , ,000 BE InVivoMab anti-mouse CD28 Syrian hamster IgG , ,000 BE InVivoMab anti-mouse CD28 Syrian hamster IgG , ,000 BE PV-1 InVivoMab anti-mouse CD28 Armenian hamster IgG 1 15,000 22,000 BE PV-1 InVivoMab anti-mouse CD28 Armenian hamster IgG 5 55,000 77,000 BE PV-1 InVivoMab anti-mouse CD28 Armenian hamster IgG , ,000 BE PV-1 InVivoMab anti-mouse CD28 Armenian hamster IgG , ,000 BE PV-1 InVivoMab anti-mouse CD28 Armenian hamster IgG , ,000 BE FGK4.5/FGK45 InVivoMab anti-mouse CD40 rat IgG2a 1 15,000 22,000 BE FGK4.5/FGK45 InVivoMab anti-mouse CD40 rat IgG2a 5 55,000 77,000 BE FGK4.5/FGK45 InVivoMab anti-mouse CD40 rat IgG2a , ,000 BE FGK4.5/FGK45 InVivoMab anti-mouse CD40 rat IgG2a , ,000 BE FGK4.5/FGK45 InVivoMab anti-mouse CD40 rat IgG2a , ,000 BE MR-1 InVivoMab anti-mouse CD154 (CD40L) Armenian hamster IgG 1 15,000 22,000 BE MR-1 InVivoMab anti-mouse CD154 (CD40L) Armenian hamster IgG 5 55,000 77,000 BE MR-1 InVivoMab anti-mouse CD154 (CD40L) Armenian hamster IgG , ,000 BE MR-1 InVivoMab anti-mouse CD154 (CD40L) Armenian hamster IgG , ,000 BE MR-1 InVivoMab anti-mouse CD154 (CD40L) Armenian hamster IgG , ,000 BE0019 MB23G2 (HB220) InVivoMab anti-mouse CD45RB rat IgG2a 1 15,000 22,000 2 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
3 BE0019 MB23G2 (HB220) InVivoMab anti-mouse CD45RB rat IgG2a 5 55,000 77,000 BE0019 MB23G2 (HB220) InVivoMab anti-mouse CD45RB rat IgG2a , ,000 BE0019 MB23G2 (HB220) InVivoMab anti-mouse CD45RB rat IgG2a , ,000 BE0019 MB23G2 (HB220) InVivoMab anti-mouse CD45RB rat IgG2a , ,000 BE B6H12 InVivoMab anti-human CD47 mouse IgG1 1 15,000 22,000 BE B6H12 InVivoMab anti-human CD47 mouse IgG1 5 55,000 77,000 BE B6H12 InVivoMab anti-human CD47 mouse IgG , ,000 BE B6H12 InVivoMab anti-human CD47 mouse IgG , ,000 BE B6H12 InVivoMab anti-human CD47 mouse IgG , ,000 BE YN1/1.7.4 InVivoMab anti-mouse CD54 (ICAM-1) rat IgG2b 1 15,000 22,000 BE YN1/1.7.4 InVivoMab anti-mouse CD54 (ICAM-1) rat IgG2b 5 55,000 77,000 BE YN1/1.7.4 InVivoMab anti-mouse CD54 (ICAM-1) rat IgG2b , ,000 BE YN1/1.7.4 InVivoMab anti-mouse CD54 (ICAM-1) rat IgG2b , ,000 BE YN1/1.7.4 InVivoMab anti-mouse CD54 (ICAM-1) rat IgG2b , ,000 BE R6-5-D6 InVivoMab anti-human CD54 (ICAM-1) mouse IgG2a 1 15,000 22,000 BE R6-5-D6 InVivoMab anti-human CD54 (ICAM-1) mouse IgG2a 5 55,000 77,000 BE R6-5-D6 InVivoMab anti-human CD54 (ICAM-1) mouse IgG2a , ,000 BE R6-5-D6 InVivoMab anti-human CD54 (ICAM-1) mouse IgG2a , ,000 BE R6-5-D6 InVivoMab anti-human CD54 (ICAM-1) mouse IgG2a , ,000 BE0021 Mel-14 InVivoMab anti-mouse L-Selectin (CD62L) rat IgG2a 1 15,000 22,000 BE0021 Mel-14 InVivoMab anti-mouse L-Selectin (CD62L) rat IgG2a 5 55,000 77,000 BE0021 Mel-14 InVivoMab anti-mouse L-Selectin (CD62L) rat IgG2a , ,000 BE0021 Mel-14 InVivoMab anti-mouse L-Selectin (CD62L) rat IgG2a , ,000 BE0021 Mel-14 InVivoMab anti-mouse L-Selectin (CD62L) rat IgG2a , ,000 BE0022 FR70 InVivoMab anti-mouse CD70 rat IgG2b 1 15,000 22,000 BE0022 FR70 InVivoMab anti-mouse CD70 rat IgG2b 5 55,000 77,000 BE0022 FR70 InVivoMab anti-mouse CD70 rat IgG2b , ,000 BE0022 FR70 InVivoMab anti-mouse CD70 rat IgG2b , ,000 BE0022 FR70 InVivoMab anti-mouse CD70 rat IgG2b , ,000 BE0023 OKT9 InVivoMab anti-human CD71 mouse IgG1 1 15,000 22,000 BE0023 OKT9 InVivoMab anti-human CD71 mouse IgG1 5 55,000 77,000 BE0023 OKT9 InVivoMab anti-human CD71 mouse IgG , ,000 BE0023 OKT9 InVivoMab anti-human CD71 mouse IgG , ,000 BE0023 OKT9 InVivoMab anti-human CD71 mouse IgG , ,000 BE A1 InVivoMab anti-mouse CD80 (B7-1) Armenian hamster IgG2 1 15,000 22,000 BE A1 InVivoMab anti-mouse CD80 (B7-1) Armenian hamster IgG2 5 55,000 77,000 BE A1 InVivoMab anti-mouse CD80 (B7-1) Armenian hamster IgG , ,000 BE A1 InVivoMab anti-mouse CD80 (B7-1) Armenian hamster IgG , ,000 BE A1 InVivoMab anti-mouse CD80 (B7-1) Armenian hamster IgG , ,000 BE0025 GL-1 InVivoMab anti-mouse CD86 (B7-2) rat IgG2a 1 15,000 22,000 BE0025 GL-1 InVivoMab anti-mouse CD86 (B7-2) rat IgG2a 5 55,000 77,000 BE0025 GL-1 InVivoMab anti-mouse CD86 (B7-2) rat IgG2a , ,000 BE0025 GL-1 InVivoMab anti-mouse CD86 (B7-2) rat IgG2a , ,000 BE0025 GL-1 InVivoMab anti-mouse CD86 (B7-2) rat IgG2a , ,000 BE0026 M290 InVivoMab anti-mouse CD103 rat IgG2a 1 15,000 22,000 BE0026 M290 InVivoMab anti-mouse CD103 rat IgG2a 5 55,000 77,000 BE0026 M290 InVivoMab anti-mouse CD103 rat IgG2a , ,000 BE0026 M290 InVivoMab anti-mouse CD103 rat IgG2a , ,000 BE0026 M290 InVivoMab anti-mouse CD103 rat IgG2a , ,000 BE0027 M/K-2.7 InVivoMab anti-mouse CD106 (VCAM-1) rat IgG1 1 15,000 22,000 BE0027 M/K-2.7 InVivoMab anti-mouse CD106 (VCAM-1) rat IgG1 5 55,000 77,000 BE0027 M/K-2.7 InVivoMab anti-mouse CD106 (VCAM-1) rat IgG , ,000 BE0027 M/K-2.7 InVivoMab anti-mouse CD106 (VCAM-1) rat IgG , ,000 BE0027 M/K-2.7 InVivoMab anti-mouse CD106 (VCAM-1) rat IgG , ,000 BE0028 HK5.3 InVivoMab anti-mouse ICOSL (CD275) rat IgG2a 1 15,000 22,000 BE0028 HK5.3 InVivoMab anti-mouse ICOSL (CD275) rat IgG2a 5 55,000 77,000 BE0028 HK5.3 InVivoMab anti-mouse ICOSL (CD275) rat IgG2a , ,000 BE0028 HK5.3 InVivoMab anti-mouse ICOSL (CD275) rat IgG2a , ,000 BE0028 HK5.3 InVivoMab anti-mouse ICOSL (CD275) rat IgG2a , ,000 3 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
4 BE0029 GR-20 InVivoMab anti-mouse IFNγR (CD119) rat IgG2a 1 15,000 22,000 BE0029 GR-20 InVivoMab anti-mouse IFNγR (CD119) rat IgG2a 5 55,000 77,000 BE0029 GR-20 InVivoMab anti-mouse IFNγR (CD119) rat IgG2a , ,000 BE0029 GR-20 InVivoMab anti-mouse IFNγR (CD119) rat IgG2a , ,000 BE0029 GR-20 InVivoMab anti-mouse IFNγR (CD119) rat IgG2a , ,000 BE0031 OX-86 InVivoMab anti-mouse OX40 (CD134) rat IgG1 1 15,000 22,000 BE0031 OX-86 InVivoMab anti-mouse OX40 (CD134) rat IgG1 5 55,000 77,000 BE0031 OX-86 InVivoMab anti-mouse OX40 (CD134) rat IgG , ,000 BE0031 OX-86 InVivoMab anti-mouse OX40 (CD134) rat IgG , ,000 BE0031 OX-86 InVivoMab anti-mouse OX40 (CD134) rat IgG , ,000 BE0032 UC10-4F10-11 InVivoMab anti-mouse CTLA-4 (CD152) Armenian hamster IgG 1 15,000 22,000 BE0032 UC10-4F10-11 InVivoMab anti-mouse CTLA-4 (CD152) Armenian hamster IgG 5 55,000 77,000 BE0032 UC10-4F10-11 InVivoMab anti-mouse CTLA-4 (CD152) Armenian hamster IgG , ,000 BE0032 UC10-4F10-11 InVivoMab anti-mouse CTLA-4 (CD152) Armenian hamster IgG , ,000 BE0032 UC10-4F10-11 InVivoMab anti-mouse CTLA-4 (CD152) Armenian hamster IgG , ,000 BE RM134L InVivoMab anti-mouse OX40L (CD134L) rat IgG2b 1 15,000 22,000 BE RM134L InVivoMab anti-mouse OX40L (CD134L) rat IgG2b 5 55,000 77,000 BE RM134L InVivoMab anti-mouse OX40L (CD134L) rat IgG2b , ,000 BE RM134L InVivoMab anti-mouse OX40L (CD134L) rat IgG2b , ,000 BE RM134L InVivoMab anti-mouse OX40L (CD134L) rat IgG2b , ,000 BE J43 InVivoMab anti-mouse PD-1 (CD279) Armenian hamster IgG 1 15,000 22,000 BE J43 InVivoMab anti-mouse PD-1 (CD279) Armenian hamster IgG 5 55,000 77,000 BE J43 InVivoMab anti-mouse PD-1 (CD279) Armenian hamster IgG , ,000 BE J43 InVivoMab anti-mouse PD-1 (CD279) Armenian hamster IgG , ,000 BE J43 InVivoMab anti-mouse PD-1 (CD279) Armenian hamster IgG , ,000 BE0034 DATK32 InVivoMab anti-mouse LPAM-1 (Integrin α4β7) rat IgG2a 1 15,000 22,000 BE0034 DATK32 InVivoMab anti-mouse LPAM-1 (Integrin α4β7) rat IgG2a 5 55,000 77,000 BE0034 DATK32 InVivoMab anti-mouse LPAM-1 (Integrin α4β7) rat IgG2a , ,000 BE0034 DATK32 InVivoMab anti-mouse LPAM-1 (Integrin α4β7) rat IgG2a , ,000 BE0034 DATK32 InVivoMab anti-mouse LPAM-1 (Integrin α4β7) rat IgG2a , ,000 BE0035 MECA-367 InVivoMab anti-mouse MAdCAM-1 rat IgG2a 1 15,000 22,000 BE0035 MECA-367 InVivoMab anti-mouse MAdCAM-1 rat IgG2a 5 55,000 77,000 BE0035 MECA-367 InVivoMab anti-mouse MAdCAM-1 rat IgG2a , ,000 BE0035 MECA-367 InVivoMab anti-mouse MAdCAM-1 rat IgG2a , ,000 BE0035 MECA-367 InVivoMab anti-mouse MAdCAM-1 rat IgG2a , ,000 BE0036 PK136 InVivoMab anti-mouse NK1.1 mouse IgG2a 1 15,000 22,000 BE0036 PK136 InVivoMab anti-mouse NK1.1 mouse IgG2a 5 55,000 77,000 BE0036 PK136 InVivoMab anti-mouse NK1.1 mouse IgG2a , ,000 BE0036 PK136 InVivoMab anti-mouse NK1.1 mouse IgG2a , ,000 BE0036 PK136 InVivoMab anti-mouse NK1.1 mouse IgG2a , ,000 BE0039 IM7 InVivoMab anti-mouse/human CD44 rat IgG2b 1 15,000 22,000 BE0039 IM7 InVivoMab anti-mouse/human CD44 rat IgG2b 5 55,000 77,000 BE0039 IM7 InVivoMab anti-mouse/human CD44 rat IgG2b , ,000 BE0039 IM7 InVivoMab anti-mouse/human CD44 rat IgG2b , ,000 BE0039 IM7 InVivoMab anti-mouse/human CD44 rat IgG2b , ,000 BE0040 JJ319 InVivoMab anti-rat CD28 mouse IgG1 1 15,000 22,000 BE0040 JJ319 InVivoMab anti-rat CD28 mouse IgG1 5 55,000 77,000 BE0040 JJ319 InVivoMab anti-rat CD28 mouse IgG , ,000 BE0040 JJ319 InVivoMab anti-rat CD28 mouse IgG , ,000 BE0040 JJ319 InVivoMab anti-rat CD28 mouse IgG , ,000 BE0042 JES6-5H4 InVivoMab anti-mouse IL-2 rat IgG2b 1 15,000 22,000 BE0042 JES6-5H4 InVivoMab anti-mouse IL-2 rat IgG2b 5 55,000 77,000 BE0042 JES6-5H4 InVivoMab anti-mouse IL-2 rat IgG2b , ,000 BE0042 JES6-5H4 InVivoMab anti-mouse IL-2 rat IgG2b , ,000 BE0042 JES6-5H4 InVivoMab anti-mouse IL-2 rat IgG2b , ,000 BE0043 JES6-1A12 InVivoMab anti-mouse IL-2 rat IgG2a 1 15,000 22,000 BE0043 JES6-1A12 InVivoMab anti-mouse IL-2 rat IgG2a 5 55,000 77,000 BE0043 JES6-1A12 InVivoMab anti-mouse IL-2 rat IgG2a , ,000 BE0043 JES6-1A12 InVivoMab anti-mouse IL-2 rat IgG2a , ,000 BE0043 JES6-1A12 InVivoMab anti-mouse IL-2 rat IgG2a , ,000 BE S4B6-1 InVivoMab anti-mouse IL-2 rat IgG2a 1 15,000 22,000 BE S4B6-1 InVivoMab anti-mouse IL-2 rat IgG2a 5 55,000 77,000 BE S4B6-1 InVivoMab anti-mouse IL-2 rat IgG2a , ,000 4 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
5 BE S4B6-1 InVivoMab anti-mouse IL-2 rat IgG2a , ,000 BE S4B6-1 InVivoMab anti-mouse IL-2 rat IgG2a , ,000 BE B11 InVivoMab anti-mouse IL-4 rat IgG1 1 15,000 22,000 BE B11 InVivoMab anti-mouse IL-4 rat IgG1 5 55,000 77,000 BE B11 InVivoMab anti-mouse IL-4 rat IgG , ,000 BE B11 InVivoMab anti-mouse IL-4 rat IgG , ,000 BE B11 InVivoMab anti-mouse IL-4 rat IgG , ,000 BE0046 MP5-20F3 InVivoMab anti-mouse IL-6 rat IgG1 1 15,000 22,000 BE0046 MP5-20F3 InVivoMab anti-mouse IL-6 rat IgG1 5 55,000 77,000 BE0046 MP5-20F3 InVivoMab anti-mouse IL-6 rat IgG , ,000 BE0046 MP5-20F3 InVivoMab anti-mouse IL-6 rat IgG , ,000 BE0046 MP5-20F3 InVivoMab anti-mouse IL-6 rat IgG , ,000 BE A7 InVivoMab anti-mouse IL-6R rat IgG2b 1 15,000 22,000 BE A7 InVivoMab anti-mouse IL-6R rat IgG2b 5 55,000 77,000 BE A7 InVivoMab anti-mouse IL-6R rat IgG2b , ,000 BE A7 InVivoMab anti-mouse IL-6R rat IgG2b , ,000 BE A7 InVivoMab anti-mouse IL-6R rat IgG2b , ,000 BE0048 M25 InVivoMab anti-mouse/human IL-7 mouse IgG2b 1 15,000 22,000 BE0048 M25 InVivoMab anti-mouse/human IL-7 mouse IgG2b 5 55,000 77,000 BE0048 M25 InVivoMab anti-mouse/human IL-7 mouse IgG2b , ,000 BE0048 M25 InVivoMab anti-mouse/human IL-7 mouse IgG2b , ,000 BE0048 M25 InVivoMab anti-mouse/human IL-7 mouse IgG2b , ,000 BE0049 JES5-2A5 InVivoMab anti-mouse IL-10 rat IgG1 1 15,000 22,000 BE0049 JES5-2A5 InVivoMab anti-mouse IL-10 rat IgG1 5 55,000 77,000 BE0049 JES5-2A5 InVivoMab anti-mouse IL-10 rat IgG , ,000 BE0049 JES5-2A5 InVivoMab anti-mouse IL-10 rat IgG , ,000 BE0049 JES5-2A5 InVivoMab anti-mouse IL-10 rat IgG , ,000 BE0050 1B1.3A InVivoMab anti-mouse IL-10R (CD210) rat IgG1 1 15,000 22,000 BE0050 1B1.3A InVivoMab anti-mouse IL-10R (CD210) rat IgG1 5 55,000 77,000 BE0050 1B1.3A InVivoMab anti-mouse IL-10R (CD210) rat IgG , ,000 BE0050 1B1.3A InVivoMab anti-mouse IL-10R (CD210) rat IgG , ,000 BE0050 1B1.3A InVivoMab anti-mouse IL-10R (CD210) rat IgG , ,000 BE0051 C17.8 InVivoMab anti-mouse IL-12 p40 rat IgG2a 1 15,000 22,000 BE0051 C17.8 InVivoMab anti-mouse IL-12 p40 rat IgG2a 5 55,000 77,000 BE0051 C17.8 InVivoMab anti-mouse IL-12 p40 rat IgG2a , ,000 BE0051 C17.8 InVivoMab anti-mouse IL-12 p40 rat IgG2a , ,000 BE0051 C17.8 InVivoMab anti-mouse IL-12 p40 rat IgG2a , ,000 BE0052 R1-5D9 InVivoMab anti-mouse IL-12 rat IgG2a 1 15,000 22,000 BE0052 R1-5D9 InVivoMab anti-mouse IL-12 rat IgG2a 5 55,000 77,000 BE0052 R1-5D9 InVivoMab anti-mouse IL-12 rat IgG2a , ,000 BE0052 R1-5D9 InVivoMab anti-mouse IL-12 rat IgG2a , ,000 BE0052 R1-5D9 InVivoMab anti-mouse IL-12 rat IgG2a , ,000 BE0054 R4-6A2 InVivoMab anti-mouse IFNγ rat IgG1 1 15,000 22,000 BE0054 R4-6A2 InVivoMab anti-mouse IFNγ rat IgG1 5 55,000 77,000 BE0054 R4-6A2 InVivoMab anti-mouse IFNγ rat IgG , ,000 BE0054 R4-6A2 InVivoMab anti-mouse IFNγ rat IgG , ,000 BE0054 R4-6A2 InVivoMab anti-mouse IFNγ rat IgG , ,000 BE0055 XMG1.2 InVivoMab anti-mouse IFNγ rat IgG1 1 15,000 22,000 BE0055 XMG1.2 InVivoMab anti-mouse IFNγ rat IgG1 5 55,000 77,000 BE0055 XMG1.2 InVivoMab anti-mouse IFNγ rat IgG , ,000 BE0055 XMG1.2 InVivoMab anti-mouse IFNγ rat IgG , ,000 BE0055 XMG1.2 InVivoMab anti-mouse IFNγ rat IgG , ,000 InVivoMab antimouse/human/rat/monkey/hamster/canine/bovine BE0057 1D TGF-β mouse IgG1 1 15,000 22,000 InVivoMab antimouse/human/rat/monkey/hamster/canine/bovine BE0057 1D TGF-β mouse IgG1 5 55,000 77,000 InVivoMab antimouse/human/rat/monkey/hamster/canine/bovine BE0057 1D TGF-β mouse IgG , ,000 InVivoMab antimouse/human/rat/monkey/hamster/canine/bovine BE0057 1D TGF-β mouse IgG , ,000 5 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
6 InVivoMab antimouse/human/rat/monkey/hamster/canine/bovine BE0057 1D TGF-β mouse IgG , ,000 BE0058 XT3.11 InVivoMab anti-mouse TNFα rat IgG1 1 15,000 22,000 BE0058 XT3.11 InVivoMab anti-mouse TNFα rat IgG1 5 55,000 77,000 BE0058 XT3.11 InVivoMab anti-mouse TNFα rat IgG , ,000 BE0058 XT3.11 InVivoMab anti-mouse TNFα rat IgG , ,000 BE0058 XT3.11 InVivoMab anti-mouse TNFα rat IgG , ,000 BE0059 7E.17G9 InVivoMab anti-mouse ICOS rat IgG2b 1 15,000 22,000 BE0059 7E.17G9 InVivoMab anti-mouse ICOS rat IgG2b 5 55,000 77,000 BE0059 7E.17G9 InVivoMab anti-mouse ICOS rat IgG2b , ,000 BE0059 7E.17G9 InVivoMab anti-mouse ICOS rat IgG2b , ,000 BE0059 7E.17G9 InVivoMab anti-mouse ICOS rat IgG2b , ,000 BE0060 DC101 InVivoMab anti-mouse VEGFR-2 rat IgG1 1 15,000 22,000 BE0060 DC101 InVivoMab anti-mouse VEGFR-2 rat IgG1 5 55,000 77,000 BE0060 DC101 InVivoMab anti-mouse VEGFR-2 rat IgG , ,000 BE0060 DC101 InVivoMab anti-mouse VEGFR-2 rat IgG , ,000 BE0060 DC101 InVivoMab anti-mouse VEGFR-2 rat IgG , ,000 BE InVivoMab anti-mouse CD8α rat IgG2b 1 15,000 22,000 BE InVivoMab anti-mouse CD8α rat IgG2b 5 55,000 77,000 BE InVivoMab anti-mouse CD8α rat IgG2b , ,000 BE InVivoMab anti-mouse CD8α rat IgG2b , ,000 BE InVivoMab anti-mouse CD8α rat IgG2b , ,000 BE0062 FIB504 InVivoMab anti-mouse/human Integrin β7 rat IgG2a 1 15,000 22,000 BE0062 FIB504 InVivoMab anti-mouse/human Integrin β7 rat IgG2a 5 55,000 77,000 BE0062 FIB504 InVivoMab anti-mouse/human Integrin β7 rat IgG2a , ,000 BE0062 FIB504 InVivoMab anti-mouse/human Integrin β7 rat IgG2a , ,000 BE0062 FIB504 InVivoMab anti-mouse/human Integrin β7 rat IgG2a , ,000 BE0063 DTA-1 InVivoMab anti-mouse GITR rat IgG2b 1 15,000 22,000 BE0063 DTA-1 InVivoMab anti-mouse GITR rat IgG2b 5 55,000 77,000 BE0063 DTA-1 InVivoMab anti-mouse GITR rat IgG2b , ,000 BE0063 DTA-1 InVivoMab anti-mouse GITR rat IgG2b , ,000 BE0063 DTA-1 InVivoMab anti-mouse GITR rat IgG2b , ,000 BE0065 A7R34 InVivoMab anti-mouse IL-7Rα (CD127) rat IgG2a 1 15,000 22,000 BE0065 A7R34 InVivoMab anti-mouse IL-7Rα (CD127) rat IgG2a 5 55,000 77,000 BE0065 A7R34 InVivoMab anti-mouse IL-7Rα (CD127) rat IgG2a , ,000 BE0065 A7R34 InVivoMab anti-mouse IL-7Rα (CD127) rat IgG2a , ,000 BE0065 A7R34 InVivoMab anti-mouse IL-7Rα (CD127) rat IgG2a , ,000 BE H12 InVivoMab anti-mouse Thy1.2 (CD90.2) rat IgG2b 1 15,000 22,000 BE H12 InVivoMab anti-mouse Thy1.2 (CD90.2) rat IgG2b 5 55,000 77,000 BE H12 InVivoMab anti-mouse Thy1.2 (CD90.2) rat IgG2b , ,000 BE H12 InVivoMab anti-mouse Thy1.2 (CD90.2) rat IgG2b , ,000 BE H12 InVivoMab anti-mouse Thy1.2 (CD90.2) rat IgG2b , ,000 BE0067 RA3.3A1/6.1 InVivoMab anti-mouse B220 rat IgM 1 15,000 22,000 BE0067 RA3.3A1/6.1 InVivoMab anti-mouse B220 rat IgM 5 55,000 77,000 BE0067 RA3.3A1/6.1 InVivoMab anti-mouse B220 rat IgM , ,000 BE0067 RA3.3A1/6.1 InVivoMab anti-mouse B220 rat IgM , ,000 BE0067 RA3.3A1/6.1 InVivoMab anti-mouse B220 rat IgM , ,000 InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I- BE As,I-Ag7) mouse IgG2a 1 15,000 22,000 InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I- BE As,I-Ag7) mouse IgG2a 5 55,000 77,000 InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I- BE As,I-Ag7) mouse IgG2a , ,000 InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I- BE As,I-Ag7) mouse IgG2a , ,000 InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I- BE As,I-Ag7) mouse IgG2a , ,000 BE0069 1B2 InVivoMab anti-mouse 2C TCR mouse IgG1 1 15,000 22,000 BE0069 1B2 InVivoMab anti-mouse 2C TCR mouse IgG1 5 55,000 77,000 BE0069 1B2 InVivoMab anti-mouse 2C TCR mouse IgG , ,000 BE0069 1B2 InVivoMab anti-mouse 2C TCR mouse IgG , ,000 BE0069 1B2 InVivoMab anti-mouse 2C TCR mouse IgG , ,000 BE0070 UC7-13D5 InVivoMab anti-mouse TCR γ/δ Armenian hamster IgG 1 15,000 22,000 6 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
7 BE0070 UC7-13D5 InVivoMab anti-mouse TCR γ/δ Armenian hamster IgG 5 55,000 77,000 BE0070 UC7-13D5 InVivoMab anti-mouse TCR γ/δ Armenian hamster IgG , ,000 BE0070 UC7-13D5 InVivoMab anti-mouse TCR γ/δ Armenian hamster IgG , ,000 BE0070 UC7-13D5 InVivoMab anti-mouse TCR γ/δ Armenian hamster IgG , ,000 BE0071 PS/2 InVivoMab anti-mouse/human VLA-4 (CD49d) rat IgG2b 1 15,000 22,000 BE0071 PS/2 InVivoMab anti-mouse/human VLA-4 (CD49d) rat IgG2b 5 55,000 77,000 BE0071 PS/2 InVivoMab anti-mouse/human VLA-4 (CD49d) rat IgG2b , ,000 BE0071 PS/2 InVivoMab anti-mouse/human VLA-4 (CD49d) rat IgG2b , ,000 BE0071 PS/2 InVivoMab anti-mouse/human VLA-4 (CD49d) rat IgG2b , ,000 InVivoMab anti-mouse T15 VH and T15 VL regions of BE0072 AB1-2 (HB-33) IgM mouse IgG1 1 15,000 22,000 InVivoMab anti-mouse T15 VH and T15 VL regions of BE0072 AB1-2 (HB-33) IgM mouse IgG1 5 55,000 77,000 InVivoMab anti-mouse T15 VH and T15 VL regions of BE0072 AB1-2 (HB-33) IgM mouse IgG , ,000 InVivoMab anti-mouse T15 VH and T15 VL regions of BE0072 AB1-2 (HB-33) IgM mouse IgG , ,000 InVivoMab anti-mouse T15 VH and T15 VL regions of BE0072 AB1-2 (HB-33) IgM mouse IgG , ,000 BE0075 RB6-8C5 InVivoMab anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b 1 15,000 22,000 BE0075 RB6-8C5 InVivoMab anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b 5 55,000 77,000 BE0075 RB6-8C5 InVivoMab anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b , ,000 BE0075 RB6-8C5 InVivoMab anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b , ,000 BE0075 RB6-8C5 InVivoMab anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b , ,000 BE A8 InVivoMab anti-mouse Ly6G rat IgG2a 1 15,000 22,000 BE A8 InVivoMab anti-mouse Ly6G rat IgG2a 5 55,000 77,000 BE A8 InVivoMab anti-mouse Ly6G rat IgG2a , ,000 BE A8 InVivoMab anti-mouse Ly6G rat IgG2a , ,000 BE A8 InVivoMab anti-mouse Ly6G rat IgG2a , ,000 BE0076 M5/ InVivoMab anti-mouse Thy1 (CD90) rat IgG2a 1 15,000 22,000 BE0076 M5/ InVivoMab anti-mouse Thy1 (CD90) rat IgG2a 5 55,000 77,000 BE0076 M5/ InVivoMab anti-mouse Thy1 (CD90) rat IgG2a , ,000 BE0076 M5/ InVivoMab anti-mouse Thy1 (CD90) rat IgG2a , ,000 BE0076 M5/ InVivoMab anti-mouse Thy1 (CD90) rat IgG2a , ,000 BE0077 M1/ InVivoMab anti-mouse MHC Class I (H-2) rat IgG2a 1 15,000 22,000 BE0077 M1/ InVivoMab anti-mouse MHC Class I (H-2) rat IgG2a 5 55,000 77,000 BE0077 M1/ InVivoMab anti-mouse MHC Class I (H-2) rat IgG2a , ,000 BE0077 M1/ InVivoMab anti-mouse MHC Class I (H-2) rat IgG2a , ,000 BE0077 M1/ InVivoMab anti-mouse MHC Class I (H-2) rat IgG2a , ,000 InVivoMab anti-human MHC Class I (HLA-A, HLA-B, BE0079 W6/32 HLA-C) mouse IgG2a 1 15,000 22,000 InVivoMab anti-human MHC Class I (HLA-A, HLA-B, BE0079 W6/32 HLA-C) mouse IgG2a 5 55,000 77,000 InVivoMab anti-human MHC Class I (HLA-A, HLA-B, BE0079 W6/32 HLA-C) mouse IgG2a , ,000 InVivoMab anti-human MHC Class I (HLA-A, HLA-B, BE0079 W6/32 HLA-C) mouse IgG2a , ,000 InVivoMab anti-human MHC Class I (HLA-A, HLA-B, BE0079 W6/32 HLA-C) mouse IgG2a , ,000 BE0083 MOPC-21 InVivoMab mouse IgG1 isotype control mouse IgG1 1 15,000 22,000 BE0083 MOPC-21 InVivoMab mouse IgG1 isotype control mouse IgG1 5 55,000 77,000 BE0083 MOPC-21 InVivoMab mouse IgG1 isotype control mouse IgG , ,000 BE0083 MOPC-21 InVivoMab mouse IgG1 isotype control mouse IgG , ,000 BE0083 MOPC-21 InVivoMab mouse IgG1 isotype control mouse IgG , ,000 BE0085 C InVivoMab mouse IgG2a isotype control mouse IgG2a 1 15,000 22,000 BE0085 C InVivoMab mouse IgG2a isotype control mouse IgG2a 5 55,000 77,000 BE0085 C InVivoMab mouse IgG2a isotype control mouse IgG2a , ,000 BE0085 C InVivoMab mouse IgG2a isotype control mouse IgG2a , ,000 BE0085 C InVivoMab mouse IgG2a isotype control mouse IgG2a , ,000 BE0086 MPC-11 InVivoMab mouse IgG2b isotype control mouse IgG2b 1 15,000 22,000 BE0086 MPC-11 InVivoMab mouse IgG2b isotype control mouse IgG2b 5 55,000 77,000 BE0086 MPC-11 InVivoMab mouse IgG2b isotype control mouse IgG2b , ,000 BE0086 MPC-11 InVivoMab mouse IgG2b isotype control mouse IgG2b , ,000 BE0086 MPC-11 InVivoMab mouse IgG2b isotype control mouse IgG2b , ,000 7 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
8 BE0087 Polyclonal Syrian InVivoMab polyclonal Syrian hamster IgG Syrian hamster IgG 1 15,000 22,000 BE0087 Polyclonal Syrian InVivoMab polyclonal Syrian hamster IgG Syrian hamster IgG 5 55,000 77,000 BE0087 Polyclonal Syrian InVivoMab polyclonal Syrian hamster IgG Syrian hamster IgG , ,000 BE0087 Polyclonal Syrian InVivoMab polyclonal Syrian hamster IgG Syrian hamster IgG , ,000 BE0087 Polyclonal Syrian InVivoMab polyclonal Syrian hamster IgG Syrian hamster IgG , ,000 BE0088 HRPN InVivoMab rat IgG1 isotype control (anti-hrp) rat IgG1 1 15,000 22,000 BE0088 HRPN InVivoMab rat IgG1 isotype control (anti-hrp) rat IgG1 5 55,000 77,000 BE0088 HRPN InVivoMab rat IgG1 isotype control (anti-hrp) rat IgG , ,000 BE0088 HRPN InVivoMab rat IgG1 isotype control (anti-hrp) rat IgG , ,000 BE0088 HRPN InVivoMab rat IgG1 isotype control (anti-hrp) rat IgG , ,000 BE0089 2A3 InVivoMab rat IgG2a isotype control rat IgG2a 1 15,000 22,000 BE0089 2A3 InVivoMab rat IgG2a isotype control rat IgG2a 5 55,000 77,000 BE0089 2A3 InVivoMab rat IgG2a isotype control rat IgG2a , ,000 BE0089 2A3 InVivoMab rat IgG2a isotype control rat IgG2a , ,000 BE0089 2A3 InVivoMab rat IgG2a isotype control rat IgG2a , ,000 BE0090 LTF-2 InVivoMab rat IgG2b isotype control rat IgG2b 1 15,000 22,000 BE0090 LTF-2 InVivoMab rat IgG2b isotype control rat IgG2b 5 55,000 77,000 BE0090 LTF-2 InVivoMab rat IgG2b isotype control rat IgG2b , ,000 BE0090 LTF-2 InVivoMab rat IgG2b isotype control rat IgG2b , ,000 BE0090 LTF-2 InVivoMab rat IgG2b isotype control rat IgG2b , ,000 BE0091 Polyclonal Armenian InVivoMab polyclonal Armenian hamster IgG Armenian hamster IgG 1 15,000 22,000 BE0091 Polyclonal Armenian InVivoMab polyclonal Armenian hamster IgG Armenian hamster IgG 5 55,000 77,000 BE0091 Polyclonal Armenian InVivoMab polyclonal Armenian hamster IgG Armenian hamster IgG , ,000 BE0091 Polyclonal Armenian InVivoMab polyclonal Armenian hamster IgG Armenian hamster IgG , ,000 BE0091 Polyclonal Armenian InVivoMab polyclonal Armenian hamster IgG Armenian hamster IgG , ,000 hamster IgG f(ab )2 BE0091-FAB Fragments InVivoMab Armenian hamster IgG f(ab )2 fragments Polyclonal 5 78, ,000 hamster IgG f(ab )2 BE0091-FAB Fragments InVivoMab Armenian hamster IgG f(ab )2 fragments Polyclonal , ,000 hamster IgG f(ab )2 BE0091-FAB Fragments InVivoMab Armenian hamster IgG f(ab )2 fragments Polyclonal , ,000 hamster IgG f(ab )2 BE0091-FAB Fragments InVivoMab Armenian hamster IgG f(ab )2 fragments Polyclonal , ,000 BE0092 Polyclonal InVivoMab polyclonal human IgG human IgG 1 15,000 22,000 BE0092 Polyclonal InVivoMab polyclonal human IgG human IgG 5 55,000 77,000 BE0092 Polyclonal InVivoMab polyclonal human IgG human IgG , ,000 BE0092 Polyclonal InVivoMab polyclonal human IgG human IgG , ,000 BE0092 Polyclonal InVivoMab polyclonal human IgG human IgG , ,000 BE0093 Polyclonal InVivoMab polyclonal mouse IgG mouse IgG 1 15,000 22,000 BE0093 Polyclonal InVivoMab polyclonal mouse IgG mouse IgG 5 55,000 77,000 BE0093 Polyclonal InVivoMab polyclonal mouse IgG mouse IgG , ,000 BE0093 Polyclonal InVivoMab polyclonal mouse IgG mouse IgG , ,000 BE0093 Polyclonal InVivoMab polyclonal mouse IgG mouse IgG , ,000 BE0094 Polyclonal InVivoMab polyclonal rat IgG rat IgG 1 15,000 22,000 BE0094 Polyclonal InVivoMab polyclonal rat IgG rat IgG 5 55,000 77,000 BE0094 Polyclonal InVivoMab polyclonal rat IgG rat IgG , ,000 BE0094 Polyclonal InVivoMab polyclonal rat IgG rat IgG , ,000 BE0094 Polyclonal InVivoMab polyclonal rat IgG rat IgG , ,000 BE0096 human Fc-G1 InVivoMab recombinant human IgG1 Fc Rabbit IgG 1 15,000 22,000 BE0096 human Fc-G1 InVivoMab recombinant human IgG1 Fc Rabbit IgG 5 55,000 77,000 BE0096 human Fc-G1 InVivoMab recombinant human IgG1 Fc Rabbit IgG , ,000 BE0096 human Fc-G1 InVivoMab recombinant human IgG1 Fc Rabbit IgG , ,000 BE0096 human Fc-G1 InVivoMab recombinant human IgG1 Fc Rabbit IgG , ,000 BE0097 mouse Fc G2a InVivoMab recombinant mouse IgG2a Fc Rabbit IgG 1 15,000 22,000 BE0097 mouse Fc G2a InVivoMab recombinant mouse IgG2a Fc Rabbit IgG 5 55,000 77,000 BE0097 mouse Fc G2a InVivoMab recombinant mouse IgG2a Fc Rabbit IgG , ,000 BE0097 mouse Fc G2a InVivoMab recombinant mouse IgG2a Fc Rabbit IgG , ,000 BE0097 mouse Fc G2a InVivoMab recombinant mouse IgG2a Fc Rabbit IgG , ,000 BE0098 Flt-3L-Ig (hum./hum.) InVivoMab recombinant Flt-3L-Ig (hum./hum.) Rabbit IgG , ,000 BE0098 Flt-3L-Ig (hum./hum.) InVivoMab recombinant Flt-3L-Ig (hum./hum.) Rabbit IgG , ,000 BE0098 Flt-3L-Ig (hum./hum.) InVivoMab recombinant Flt-3L-Ig (hum./hum.) Rabbit IgG ,000 1,323,000 BE0099 CTLA-4-Ig (hum./hum.) InVivoMab recombinant CTLA-4-Ig (hum./hum.) Rabbit IgG 5 55,000 84,000 BE0099 CTLA-4-Ig (hum./hum.) InVivoMab recombinant CTLA-4-Ig (hum./hum.) Rabbit IgG , ,000 BE0099 CTLA-4-Ig (hum./hum.) InVivoMab recombinant CTLA-4-Ig (hum./hum.) Rabbit IgG , ,000 8 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
9 BE0099 CTLA-4-Ig (hum./hum.) InVivoMab recombinant CTLA-4-Ig (hum./hum.) Rabbit IgG , ,000 BE0100 4B10 InVivoMab anti-mouse/human T-bet mouse IgG1 1 15,000 22,000 BE0100 4B10 InVivoMab anti-mouse/human T-bet mouse IgG1 5 55,000 77,000 BE0100 4B10 InVivoMab anti-mouse/human T-bet mouse IgG , ,000 BE0100 4B10 InVivoMab anti-mouse/human T-bet mouse IgG , ,000 BE0100 4B10 InVivoMab anti-mouse/human T-bet mouse IgG , ,000 BE F.9G2 InVivoMab anti-mouse PD-L1 (B7-H1) rat IgG2b 1 15,000 22,000 BE F.9G2 InVivoMab anti-mouse PD-L1 (B7-H1) rat IgG2b 5 55,000 84,000 BE F.9G2 InVivoMab anti-mouse PD-L1 (B7-H1) rat IgG2b , ,000 BE F.9G2 InVivoMab anti-mouse PD-L1 (B7-H1) rat IgG2b , ,000 BE F.9G2 InVivoMab anti-mouse PD-L1 (B7-H1) rat IgG2b , ,000 BE0102 H (HB-218) InVivoMab anti-mouse TCRβ Armenian hamster IgG 1 15,000 22,000 BE0102 H (HB-218) InVivoMab anti-mouse TCRβ Armenian hamster IgG 5 55,000 77,000 BE0102 H (HB-218) InVivoMab anti-mouse TCRβ Armenian hamster IgG , ,000 BE0102 H (HB-218) InVivoMab anti-mouse TCRβ Armenian hamster IgG , ,000 BE0102 H (HB-218) InVivoMab anti-mouse TCRβ Armenian hamster IgG , ,000 BE0104 SF (HB-159) InVivoMab anti-mouse MHC Class I (H-2Kd) mouse IgG2a 1 15,000 22,000 BE0104 SF (HB-159) InVivoMab anti-mouse MHC Class I (H-2Kd) mouse IgG2a 5 55,000 77,000 BE0104 SF (HB-159) InVivoMab anti-mouse MHC Class I (H-2Kd) mouse IgG2a , ,000 BE0104 SF (HB-159) InVivoMab anti-mouse MHC Class I (H-2Kd) mouse IgG2a , ,000 BE0104 SF (HB-159) InVivoMab anti-mouse MHC Class I (H-2Kd) mouse IgG2a , ,000 BE0106 VL-4 InVivoMab anti-lcmv nucleoprotein rat IgG2a 1 15,000 22,000 BE0106 VL-4 InVivoMab anti-lcmv nucleoprotein rat IgG2a 5 55,000 77,000 BE0106 VL-4 InVivoMab anti-lcmv nucleoprotein rat IgG2a , ,000 BE0106 VL-4 InVivoMab anti-lcmv nucleoprotein rat IgG2a , ,000 BE0106 VL-4 InVivoMab anti-lcmv nucleoprotein rat IgG2a , ,000 BE0108 M5/114 InVivoMab anti-mouse MHC Class II (I-A/I-E) rat IgG2b 1 15,000 22,000 BE0108 M5/114 InVivoMab anti-mouse MHC Class II (I-A/I-E) rat IgG2b 5 55,000 77,000 BE0108 M5/114 InVivoMab anti-mouse MHC Class II (I-A/I-E) rat IgG2b , ,000 BE0108 M5/114 InVivoMab anti-mouse MHC Class II (I-A/I-E) rat IgG2b , ,000 BE0108 M5/114 InVivoMab anti-mouse MHC Class II (I-A/I-E) rat IgG2b , ,000 BE0110 TKS-1 InVivoMab anti-mouse 4-1BBL (CD137L) rat IgG2a 1 15,000 22,000 BE0110 TKS-1 InVivoMab anti-mouse 4-1BBL (CD137L) rat IgG2a 5 55,000 77,000 BE0110 TKS-1 InVivoMab anti-mouse 4-1BBL (CD137L) rat IgG2a , ,000 BE0110 TKS-1 InVivoMab anti-mouse 4-1BBL (CD137L) rat IgG2a , ,000 BE0110 TKS-1 InVivoMab anti-mouse 4-1BBL (CD137L) rat IgG2a , ,000 BE0111 HMG2D InVivoMab anti-mouse NKG2D Armenian hamster IgG 1 15,000 22,000 BE0111 HMG2D InVivoMab anti-mouse NKG2D Armenian hamster IgG 5 55,000 77,000 BE0111 HMG2D InVivoMab anti-mouse NKG2D Armenian hamster IgG , ,000 BE0111 HMG2D InVivoMab anti-mouse NKG2D Armenian hamster IgG , ,000 BE0111 HMG2D InVivoMab anti-mouse NKG2D Armenian hamster IgG , ,000 BE0112 TY25 InVivoMab anti-mouse PD-L2 (B7-DC) rat IgG2a 1 15,000 22,000 BE0112 TY25 InVivoMab anti-mouse PD-L2 (B7-DC) rat IgG2a 5 55,000 77,000 BE0112 TY25 InVivoMab anti-mouse PD-L2 (B7-DC) rat IgG2a , ,000 BE0112 TY25 InVivoMab anti-mouse PD-L2 (B7-DC) rat IgG2a , ,000 BE0112 TY25 InVivoMab anti-mouse PD-L2 (B7-DC) rat IgG2a , ,000 BE0113 RMT1-10 InVivoMab anti-mouse TIM-1 (CD365) rat IgG2a 1 15,000 22,000 BE0113 RMT1-10 InVivoMab anti-mouse TIM-1 (CD365) rat IgG2a 5 55,000 77,000 BE0113 RMT1-10 InVivoMab anti-mouse TIM-1 (CD365) rat IgG2a , ,000 BE0113 RMT1-10 InVivoMab anti-mouse TIM-1 (CD365) rat IgG2a , ,000 BE0113 RMT1-10 InVivoMab anti-mouse TIM-1 (CD365) rat IgG2a , ,000 BE0114 RMT2-29 InVivoMab anti-mouse TIM-2 rat IgM 1 15,000 22,000 BE0114 RMT2-29 InVivoMab anti-mouse TIM-2 rat IgM 5 55,000 77,000 BE0114 RMT2-29 InVivoMab anti-mouse TIM-2 rat IgM , ,000 BE0114 RMT2-29 InVivoMab anti-mouse TIM-2 rat IgM , ,000 BE0114 RMT2-29 InVivoMab anti-mouse TIM-2 rat IgM , ,000 BE0115 RMT3-23 InVivoMab anti-mouse TIM-3 (CD366) rat IgG2a 1 15,000 22,000 BE0115 RMT3-23 InVivoMab anti-mouse TIM-3 (CD366) rat IgG2a 5 55,000 77,000 BE0115 RMT3-23 InVivoMab anti-mouse TIM-3 (CD366) rat IgG2a , ,000 BE0115 RMT3-23 InVivoMab anti-mouse TIM-3 (CD366) rat IgG2a , ,000 BE0115 RMT3-23 InVivoMab anti-mouse TIM-3 (CD366) rat IgG2a , ,000 BE0117 YTS169.4 InVivoMab anti-mouse CD8α rat IgG2b 1 15,000 22,000 BE0117 YTS169.4 InVivoMab anti-mouse CD8α rat IgG2b 5 55,000 77,000 9 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
10 BE0117 YTS169.4 InVivoMab anti-mouse CD8α rat IgG2b , ,000 BE0117 YTS169.4 InVivoMab anti-mouse CD8α rat IgG2b , ,000 BE0117 YTS169.4 InVivoMab anti-mouse CD8α rat IgG2b , ,000 BE (HB-129) InVivoMab anti-mouse CD8 (Lyt 2.1) mouse IgG2a 1 15,000 22,000 BE (HB-129) InVivoMab anti-mouse CD8 (Lyt 2.1) mouse IgG2a 5 55,000 77,000 BE (HB-129) InVivoMab anti-mouse CD8 (Lyt 2.1) mouse IgG2a , ,000 BE (HB-129) InVivoMab anti-mouse CD8 (Lyt 2.1) mouse IgG2a , ,000 BE (HB-129) InVivoMab anti-mouse CD8 (Lyt 2.1) mouse IgG2a , ,000 BE0119 YTS 191 InVivoMab anti-mouse CD4 rat IgG2b 1 15,000 22,000 BE0119 YTS 191 InVivoMab anti-mouse CD4 rat IgG2b 5 55,000 77,000 BE0119 YTS 191 InVivoMab anti-mouse CD4 rat IgG2b , ,000 BE0119 YTS 191 InVivoMab anti-mouse CD4 rat IgG2b , ,000 BE0119 YTS 191 InVivoMab anti-mouse CD4 rat IgG2b , ,000 BE (HB139) InVivoMab anti-swine MHC Class I (SLAd) mouse IgG2b 1 15,000 22,000 BE (HB139) InVivoMab anti-swine MHC Class I (SLAd) mouse IgG2b 5 55,000 77,000 BE (HB139) InVivoMab anti-swine MHC Class I (SLAd) mouse IgG2b , ,000 BE (HB139) InVivoMab anti-swine MHC Class I (SLAd) mouse IgG2b , ,000 BE (HB139) InVivoMab anti-swine MHC Class I (SLAd) mouse IgG2b , ,000 BE0121 AF InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2a 1 15,000 22,000 BE0121 AF InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2a 5 55,000 77,000 BE0121 AF InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2a , ,000 BE0121 AF InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2a , ,000 BE0121 AF InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2a , ,000 InVivoMab anti-rat Kappa Immunoglobulin Light BE0122 MAR 18.5 Chain mouse IgG2a 1 15,000 22,000 InVivoMab anti-rat Kappa Immunoglobulin Light BE0122 MAR 18.5 Chain mouse IgG2a 5 55,000 77,000 InVivoMab anti-rat Kappa Immunoglobulin Light BE0122 MAR 18.5 Chain mouse IgG2a , ,000 InVivoMab anti-rat Kappa Immunoglobulin Light BE0122 MAR 18.5 Chain mouse IgG2a , ,000 InVivoMab anti-rat Kappa Immunoglobulin Light BE0122 MAR 18.5 Chain mouse IgG2a , ,000 BE0123 Mab35 (TIB-175) InVivoMab anti-human/rat/fish AChR rat IgG1 1 15,000 22,000 BE0123 Mab35 (TIB-175) InVivoMab anti-human/rat/fish AChR rat IgG1 5 55,000 77,000 BE0123 Mab35 (TIB-175) InVivoMab anti-human/rat/fish AChR rat IgG , ,000 BE0123 Mab35 (TIB-175) InVivoMab anti-human/rat/fish AChR rat IgG , ,000 BE0123 Mab35 (TIB-175) InVivoMab anti-human/rat/fish AChR rat IgG , ,000 BE0124 MJ18 InVivoMab anti-mouse B7-H3 rat IgG1 1 15,000 22,000 BE0124 MJ18 InVivoMab anti-mouse B7-H3 rat IgG1 5 55,000 77,000 BE0124 MJ18 InVivoMab anti-mouse B7-H3 rat IgG , ,000 BE0124 MJ18 InVivoMab anti-mouse B7-H3 rat IgG , ,000 BE0124 MJ18 InVivoMab anti-mouse B7-H3 rat IgG , ,000 BE0125 HMJ2-1 InVivoMab anti-mouse Jagged2 Armenian hamster IgG 1 15,000 22,000 BE0125 HMJ2-1 InVivoMab anti-mouse Jagged2 Armenian hamster IgG 5 55,000 77,000 BE0125 HMJ2-1 InVivoMab anti-mouse Jagged2 Armenian hamster IgG , ,000 BE0125 HMJ2-1 InVivoMab anti-mouse Jagged2 Armenian hamster IgG , ,000 BE0125 HMJ2-1 InVivoMab anti-mouse Jagged2 Armenian hamster IgG , ,000 BE0127 HMD4-2 InVivoMab anti-mouse Delta-like protein 4 (DLL4) Armenian hamster IgG 1 15,000 22,000 BE0127 HMD4-2 InVivoMab anti-mouse Delta-like protein 4 (DLL4) Armenian hamster IgG 5 55,000 77,000 BE0127 HMD4-2 InVivoMab anti-mouse Delta-like protein 4 (DLL4) Armenian hamster IgG , ,000 BE0127 HMD4-2 InVivoMab anti-mouse Delta-like protein 4 (DLL4) Armenian hamster IgG , ,000 BE0127 HMD4-2 InVivoMab anti-mouse Delta-like protein 4 (DLL4) Armenian hamster IgG , ,000 BE0129 HMN4-14 InVivoMab anti-mouse Notch4 Armenian hamster IgG 1 15,000 22,000 BE0129 HMN4-14 InVivoMab anti-mouse Notch4 Armenian hamster IgG 5 55,000 77,000 BE0129 HMN4-14 InVivoMab anti-mouse Notch4 Armenian hamster IgG , ,000 BE0129 HMN4-14 InVivoMab anti-mouse Notch4 Armenian hamster IgG , ,000 BE0129 HMN4-14 InVivoMab anti-mouse Notch4 Armenian hamster IgG , ,000 BE0131 9H10 InVivoMab anti-mouse CTLA-4 (CD152) Syrian hamster IgG2 1 15,000 22,000 BE0131 9H10 InVivoMab anti-mouse CTLA-4 (CD152) Syrian hamster IgG2 5 55,000 84,000 BE0131 9H10 InVivoMab anti-mouse CTLA-4 (CD152) Syrian hamster IgG , ,000 BE0131 9H10 InVivoMab anti-mouse CTLA-4 (CD152) Syrian hamster IgG , ,000 BE0131 9H10 InVivoMab anti-mouse CTLA-4 (CD152) Syrian hamster IgG , ,000 BE0132 6A6 InVivoMab anti-mouse BTLA (CD272) Armenian hamster IgG 1 15,000 22, ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
11 BE0132 6A6 InVivoMab anti-mouse BTLA (CD272) Armenian hamster IgG 5 55,000 77,000 BE0132 6A6 InVivoMab anti-mouse BTLA (CD272) Armenian hamster IgG , ,000 BE0132 6A6 InVivoMab anti-mouse BTLA (CD272) Armenian hamster IgG , ,000 BE0132 6A6 InVivoMab anti-mouse BTLA (CD272) Armenian hamster IgG , ,000 BE0133 C7 InVivoMab anti-human/bovine LDLR mouse IgG2b 1 15,000 22,000 BE0133 C7 InVivoMab anti-human/bovine LDLR mouse IgG2b 5 55,000 77,000 BE0133 C7 InVivoMab anti-human/bovine LDLR mouse IgG2b , ,000 BE0133 C7 InVivoMab anti-human/bovine LDLR mouse IgG2b , ,000 BE0133 C7 InVivoMab anti-human/bovine LDLR mouse IgG2b , ,000 BE0134 1G10 InVivoMab anti-mouse B7-1 (CD80) rat IgG2a 1 15,000 22,000 BE0134 1G10 InVivoMab anti-mouse B7-1 (CD80) rat IgG2a 5 55,000 77,000 BE0134 1G10 InVivoMab anti-mouse B7-1 (CD80) rat IgG2a , ,000 BE0134 1G10 InVivoMab anti-mouse B7-1 (CD80) rat IgG2a , ,000 BE0134 1G10 InVivoMab anti-mouse B7-1 (CD80) rat IgG2a , ,000 BE0136 CL2 InVivoMab anti-human E-Selectin mouse IgG2a 1 15,000 22,000 BE0136 CL2 InVivoMab anti-human E-Selectin mouse IgG2a 5 55,000 77,000 BE0136 CL2 InVivoMab anti-human E-Selectin mouse IgG2a , ,000 BE0136 CL2 InVivoMab anti-human E-Selectin mouse IgG2a , ,000 BE0136 CL2 InVivoMab anti-human E-Selectin mouse IgG2a , ,000 BE0139 Y InVivoMab anti-mouse/human/rat v-h-ras rat IgG2a 1 15,000 22,000 BE0139 Y InVivoMab anti-mouse/human/rat v-h-ras rat IgG2a 5 55,000 77,000 BE0139 Y InVivoMab anti-mouse/human/rat v-h-ras rat IgG2a , ,000 BE0139 Y InVivoMab anti-mouse/human/rat v-h-ras rat IgG2a , ,000 BE0139 Y InVivoMab anti-mouse/human/rat v-h-ras rat IgG2a , ,000 BE0140 KL277 InVivoMab anti-mouse MHC Class II (β chain) hamster/mouse IgG 1 15,000 22,000 BE0140 KL277 InVivoMab anti-mouse MHC Class II (β chain) hamster/mouse IgG 5 55,000 77,000 BE0140 KL277 InVivoMab anti-mouse MHC Class II (β chain) hamster/mouse IgG , ,000 BE0140 KL277 InVivoMab anti-mouse MHC Class II (β chain) hamster/mouse IgG , ,000 BE0140 KL277 InVivoMab anti-mouse MHC Class II (β chain) hamster/mouse IgG , ,000 BE InVivoMab anti-mouse 3-83 Ig rat IgG kappa 1 15,000 22,000 BE InVivoMab anti-mouse 3-83 Ig rat IgG kappa 5 55,000 77,000 BE InVivoMab anti-mouse 3-83 Ig rat IgG kappa , ,000 BE InVivoMab anti-mouse 3-83 Ig rat IgG kappa , ,000 BE InVivoMab anti-mouse 3-83 Ig rat IgG kappa , ,000 BE0143 4C9 InVivoMab anti-rat β-2-microglobulin mouse IgG1 1 15,000 22,000 BE0143 4C9 InVivoMab anti-rat β-2-microglobulin mouse IgG1 5 55,000 77,000 BE0143 4C9 InVivoMab anti-rat β-2-microglobulin mouse IgG , ,000 BE0143 4C9 InVivoMab anti-rat β-2-microglobulin mouse IgG , ,000 BE0143 4C9 InVivoMab anti-rat β-2-microglobulin mouse IgG , ,000 BE0144 2G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG1 1 15,000 22,000 BE0144 2G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG1 5 55,000 77,000 BE0144 2G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG , ,000 BE0144 2G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG , ,000 BE0144 2G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG , ,000 BE0146 RMP1-14 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a 1 15,000 22,000 BE0146 RMP1-14 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a 5 55,000 84,000 BE0146 RMP1-14 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a , ,000 BE0146 RMP1-14 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a , ,000 BE0146 RMP1-14 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a , ,000 BE0147 HM48-1 InVivoMab anti-mouse CD48 Armenian hamster IgG 1 15,000 22,000 BE0147 HM48-1 InVivoMab anti-mouse CD48 Armenian hamster IgG 5 55,000 77,000 BE0147 HM48-1 InVivoMab anti-mouse CD48 Armenian hamster IgG , ,000 BE0147 HM48-1 InVivoMab anti-mouse CD48 Armenian hamster IgG , ,000 BE0147 HM48-1 InVivoMab anti-mouse CD48 Armenian hamster IgG , ,000 BE0148 mouse Angiostatin-Ig InVivoMab recombinant mouse Angiostatin-Ig Armenian hamster IgG , ,000 BE0148 mouse Angiostatin-Ig InVivoMab recombinant mouse Angiostatin-Ig Armenian hamster IgG , ,000 BE0148 mouse Angiostatin-Ig InVivoMab recombinant mouse Angiostatin-Ig Armenian hamster IgG , ,000 BE0149 mouse Endostatin-Ig InVivoMab recombinant mouse Endostatin-Ig Armenian hamster IgG , ,000 BE0149 mouse Endostatin-Ig InVivoMab recombinant mouse Endostatin-Ig Armenian hamster IgG , ,000 BE0149 mouse Endostatin-Ig InVivoMab recombinant mouse Endostatin-Ig Armenian hamster IgG , ,000 BE0150 1D3 InVivoMab anti-mouse CD19 rat IgG2a 1 15,000 22,000 BE0150 1D3 InVivoMab anti-mouse CD19 rat IgG2a 5 55,000 77,000 BE0150 1D3 InVivoMab anti-mouse CD19 rat IgG2a , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
12 BE0150 1D3 InVivoMab anti-mouse CD19 rat IgG2a , ,000 BE0150 1D3 InVivoMab anti-mouse CD19 rat IgG2a , ,000 BE0151 TA99 InVivoMab anti-mouse/human TYRP1/TRP1 (gp75) mouse IgG2a 1 15,000 22,000 BE0151 TA99 InVivoMab anti-mouse/human TYRP1/TRP1 (gp75) mouse IgG2a 5 55,000 77,000 BE0151 TA99 InVivoMab anti-mouse/human TYRP1/TRP1 (gp75) mouse IgG2a , ,000 BE0151 TA99 InVivoMab anti-mouse/human TYRP1/TRP1 (gp75) mouse IgG2a , ,000 BE0151 TA99 InVivoMab anti-mouse/human TYRP1/TRP1 (gp75) mouse IgG2a , ,000 BE0152 AF InVivoMab anti-mouse MHC Class I (H-2Kk) mouse IgG1 1 15,000 22,000 BE0152 AF InVivoMab anti-mouse MHC Class I (H-2Kk) mouse IgG1 5 55,000 77,000 BE0152 AF InVivoMab anti-mouse MHC Class I (H-2Kk) mouse IgG , ,000 BE0152 AF InVivoMab anti-mouse MHC Class I (H-2Kk) mouse IgG , ,000 BE0152 AF InVivoMab anti-mouse MHC Class I (H-2Kk) mouse IgG , ,000 BE0153 PK18.6 InVivoMab anti-mouse BTLA (CD272) rat IgG1k 1 15,000 22,000 BE0153 PK18.6 InVivoMab anti-mouse BTLA (CD272) rat IgG1k 5 55,000 77,000 BE0153 PK18.6 InVivoMab anti-mouse BTLA (CD272) rat IgG1k , ,000 BE0153 PK18.6 InVivoMab anti-mouse BTLA (CD272) rat IgG1k , ,000 BE0153 PK18.6 InVivoMab anti-mouse BTLA (CD272) rat IgG1k , ,000 BE InVivoMab anti-hiv gp120 mouse IgG1 1 15,000 22,000 BE InVivoMab anti-hiv gp120 mouse IgG1 5 55,000 77,000 BE InVivoMab anti-hiv gp120 mouse IgG , ,000 BE InVivoMab anti-hiv gp120 mouse IgG , ,000 BE InVivoMab anti-hiv gp120 mouse IgG , ,000 BE0155 HMD1-5 InVivoMab anti-mouse Delta-like protein 1 (DLL1) Armenian hamster IgG 1 15,000 22,000 BE0155 HMD1-5 InVivoMab anti-mouse Delta-like protein 1 (DLL1) Armenian hamster IgG 5 55,000 77,000 BE0155 HMD1-5 InVivoMab anti-mouse Delta-like protein 1 (DLL1) Armenian hamster IgG , ,000 BE0155 HMD1-5 InVivoMab anti-mouse Delta-like protein 1 (DLL1) Armenian hamster IgG , ,000 BE0155 HMD1-5 InVivoMab anti-mouse Delta-like protein 1 (DLL1) Armenian hamster IgG , ,000 BE S (HB-13) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a 1 15,000 22,000 BE S (HB-13) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a 5 55,000 77,000 BE S (HB-13) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a , ,000 BE S (HB-13) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a , ,000 BE S (HB-13) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a , ,000 BE0159 H16-L10-4R5 (HB-65) InVivoMab anti-influenza A virus NP mouse IgG2a 1 15,000 22,000 BE0159 H16-L10-4R5 (HB-65) InVivoMab anti-influenza A virus NP mouse IgG2a 5 55,000 77,000 BE0159 H16-L10-4R5 (HB-65) InVivoMab anti-influenza A virus NP mouse IgG2a , ,000 BE0159 H16-L10-4R5 (HB-65) InVivoMab anti-influenza A virus NP mouse IgG2a , ,000 BE0159 H16-L10-4R5 (HB-65) InVivoMab anti-influenza A virus NP mouse IgG2a , ,000 BE0161 MD5-1 InVivoMab anti-mouse DR5 (CD262) Armenian hamster IgG 1 15,000 22,000 BE0161 MD5-1 InVivoMab anti-mouse DR5 (CD262) Armenian hamster IgG 5 55,000 77,000 BE0161 MD5-1 InVivoMab anti-mouse DR5 (CD262) Armenian hamster IgG , ,000 BE0161 MD5-1 InVivoMab anti-mouse DR5 (CD262) Armenian hamster IgG , ,000 BE0161 MD5-1 InVivoMab anti-mouse DR5 (CD262) Armenian hamster IgG , ,000 BE0162 6A7M InVivoMab anti-human Glycophorin A (type M) mouse IgG1 1 15,000 22,000 BE0162 6A7M InVivoMab anti-human Glycophorin A (type M) mouse IgG1 5 55,000 77,000 BE0162 6A7M InVivoMab anti-human Glycophorin A (type M) mouse IgG , ,000 BE0162 6A7M InVivoMab anti-human Glycophorin A (type M) mouse IgG , ,000 BE0162 6A7M InVivoMab anti-human Glycophorin A (type M) mouse IgG , ,000 BE0163 BX222 InVivoMab anti-mouse CD6 rat IgG2b 1 15,000 22,000 BE0163 BX222 InVivoMab anti-mouse CD6 rat IgG2b 5 55,000 77,000 BE0163 BX222 InVivoMab anti-mouse CD6 rat IgG2b , ,000 BE0163 BX222 InVivoMab anti-mouse CD6 rat IgG2b , ,000 BE0163 BX222 InVivoMab anti-mouse CD6 rat IgG2b , ,000 BE0164 9D9 InVivoMab anti-mouse CTLA-4 (CD152) mouse IgG2b 1 15,000 22,000 BE0164 9D9 InVivoMab anti-mouse CTLA-4 (CD152) mouse IgG2b 5 55,000 77,000 BE0164 9D9 InVivoMab anti-mouse CTLA-4 (CD152) mouse IgG2b , ,000 BE0164 9D9 InVivoMab anti-mouse CTLA-4 (CD152) mouse IgG2b , ,000 BE0164 9D9 InVivoMab anti-mouse CTLA-4 (CD152) mouse IgG2b , ,000 InVivoMab anti-mouse Nonclassical MHC Class I BE0165 4C2.4A7.5H11 molecule Qa-1b mouse IgG1 1 15,000 22,000 InVivoMab anti-mouse Nonclassical MHC Class I BE0165 4C2.4A7.5H11 molecule Qa-1b mouse IgG1 5 55,000 77,000 InVivoMab anti-mouse Nonclassical MHC Class I BE0165 4C2.4A7.5H11 molecule Qa-1b mouse IgG , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
13 InVivoMab anti-mouse Nonclassical MHC Class I BE0165 4C2.4A7.5H11 molecule Qa-1b mouse IgG , ,000 InVivoMab anti-mouse Nonclassical MHC Class I BE0165 4C2.4A7.5H11 molecule Qa-1b mouse IgG , ,000 BE0166 KT4 InVivoMab anti-mouse Vβ4 TCR rat IgG2b 1 15,000 22,000 BE0166 KT4 InVivoMab anti-mouse Vβ4 TCR rat IgG2b 5 55,000 77,000 BE0166 KT4 InVivoMab anti-mouse Vβ4 TCR rat IgG2b , ,000 BE0166 KT4 InVivoMab anti-mouse Vβ4 TCR rat IgG2b , ,000 BE0166 KT4 InVivoMab anti-mouse Vβ4 TCR rat IgG2b , ,000 BE S (HB-32) InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D) mouse IgG2a 1 15,000 22,000 BE S (HB-32) InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D) mouse IgG2a 5 55,000 77,000 BE S (HB-32) InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D) mouse IgG2a , ,000 BE S (HB-32) InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D) mouse IgG2a , ,000 BE S (HB-32) InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D) mouse IgG2a , ,000 BE0168 UC3-10A InVivoMab anti-mouse Vγ2 TCR Armenian hamster IgG 1 15,000 22,000 BE0168 UC3-10A InVivoMab anti-mouse Vγ2 TCR Armenian hamster IgG 5 55,000 77,000 BE0168 UC3-10A InVivoMab anti-mouse Vγ2 TCR Armenian hamster IgG , ,000 BE0168 UC3-10A InVivoMab anti-mouse Vγ2 TCR Armenian hamster IgG , ,000 BE0168 UC3-10A InVivoMab anti-mouse Vγ2 TCR Armenian hamster IgG , ,000 BE0169 LOB12.3 InVivoMab anti-mouse 4-1BB (CD137) rat IgG2a 1 15,000 22,000 BE0169 LOB12.3 InVivoMab anti-mouse 4-1BB (CD137) rat IgG2a 5 55,000 77,000 BE0169 LOB12.3 InVivoMab anti-mouse 4-1BB (CD137) rat IgG2a , ,000 BE0169 LOB12.3 InVivoMab anti-mouse 4-1BB (CD137) rat IgG2a , ,000 BE0169 LOB12.3 InVivoMab anti-mouse 4-1BB (CD137) rat IgG2a , ,000 BE0171 RMT4-53 InVivoMab anti-mouse TIM-4 rat IgG2a 1 15,000 22,000 BE0171 RMT4-53 InVivoMab anti-mouse TIM-4 rat IgG2a 5 55,000 77,000 BE0171 RMT4-53 InVivoMab anti-mouse TIM-4 rat IgG2a , ,000 BE0171 RMT4-53 InVivoMab anti-mouse TIM-4 rat IgG2a , ,000 BE0171 RMT4-53 InVivoMab anti-mouse TIM-4 rat IgG2a , ,000 BE0172 Y-3 InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2b 1 15,000 22,000 BE0172 Y-3 InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2b 5 55,000 77,000 BE0172 Y-3 InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2b , ,000 BE0172 Y-3 InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2b , ,000 BE0172 Y-3 InVivoMab anti-mouse MHC Class I (H-2Kb) mouse IgG2b , ,000 BE F3 InVivoMab anti-mouse IL-17A mouse IgG1 1 15,000 22,000 BE F3 InVivoMab anti-mouse IL-17A mouse IgG1 5 55,000 77,000 BE F3 InVivoMab anti-mouse IL-17A mouse IgG , ,000 BE F3 InVivoMab anti-mouse IL-17A mouse IgG , ,000 BE F3 InVivoMab anti-mouse IL-17A mouse IgG , ,000 BE0174 C9B7W InVivoMab anti-mouse LAG-3 rat IgG1 1 15,000 22,000 BE0174 C9B7W InVivoMab anti-mouse LAG-3 rat IgG1 5 55,000 77,000 BE0174 C9B7W InVivoMab anti-mouse LAG-3 rat IgG , ,000 BE0174 C9B7W InVivoMab anti-mouse LAG-3 rat IgG , ,000 BE0174 C9B7W InVivoMab anti-mouse LAG-3 rat IgG , ,000 BE0175 R /TIB-219 InVivoMab anti-mouse CD71 (TfR1) rat IgG2a 1 15,000 22,000 BE0175 R /TIB-219 InVivoMab anti-mouse CD71 (TfR1) rat IgG2a 5 55,000 77,000 BE0175 R /TIB-219 InVivoMab anti-mouse CD71 (TfR1) rat IgG2a , ,000 BE0175 R /TIB-219 InVivoMab anti-mouse CD71 (TfR1) rat IgG2a , ,000 BE0175 R /TIB-219 InVivoMab anti-mouse CD71 (TfR1) rat IgG2a , ,000 InVivoMab anti-mouse Kappa Immunoglobulin Light BE /HB-58 Chain rat IgG1 1 15,000 22,000 InVivoMab anti-mouse Kappa Immunoglobulin Light BE /HB-58 Chain rat IgG1 5 55,000 77,000 InVivoMab anti-mouse Kappa Immunoglobulin Light BE /HB-58 Chain rat IgG , ,000 InVivoMab anti-mouse Kappa Immunoglobulin Light BE /HB-58 Chain rat IgG , ,000 InVivoMab anti-mouse Kappa Immunoglobulin Light BE /HB-58 Chain rat IgG , ,000 BE0178 Y-3P InVivoMab anti-mouse MHC class II (I-A) mouse IgG2a 1 15,000 22,000 BE0178 Y-3P InVivoMab anti-mouse MHC class II (I-A) mouse IgG2a 5 55,000 77,000 BE0178 Y-3P InVivoMab anti-mouse MHC class II (I-A) mouse IgG2a , ,000 BE0178 Y-3P InVivoMab anti-mouse MHC class II (I-A) mouse IgG2a , ,000 BE0178 Y-3P InVivoMab anti-mouse MHC class II (I-A) mouse IgG2a , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
14 BE H2 (HB-323) InVivoMab anti-mouse CD1d (CD1.1) rat IgG1 1 15,000 22,000 BE H2 (HB-323) InVivoMab anti-mouse CD1d (CD1.1) rat IgG1 5 55,000 77,000 BE H2 (HB-323) InVivoMab anti-mouse CD1d (CD1.1) rat IgG , ,000 BE H2 (HB-323) InVivoMab anti-mouse CD1d (CD1.1) rat IgG , ,000 BE H2 (HB-323) InVivoMab anti-mouse CD1d (CD1.1) rat IgG , ,000 BE S InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd) mouse IgG2a 1 15,000 22,000 BE S InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd) mouse IgG2a 5 55,000 77,000 BE S InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd) mouse IgG2a , ,000 BE S InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd) mouse IgG2a , ,000 BE S InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd) mouse IgG2a , ,000 BE0181 9C1 InVivoMab anti-mouse IL-9 mouse IgG2a 1 15,000 22,000 BE0181 9C1 InVivoMab anti-mouse IL-9 mouse IgG2a 5 55,000 77,000 BE0181 9C1 InVivoMab anti-mouse IL-9 mouse IgG2a , ,000 BE0181 9C1 InVivoMab anti-mouse IL-9 mouse IgG2a , ,000 BE0181 9C1 InVivoMab anti-mouse IL-9 mouse IgG2a , ,000 BE0182 F23.1 InVivoMab anti-mouse Vβ8 TCR mouse IgG2a 1 15,000 22,000 BE0182 F23.1 InVivoMab anti-mouse Vβ8 TCR mouse IgG2a 5 55,000 77,000 BE0182 F23.1 InVivoMab anti-mouse Vβ8 TCR mouse IgG2a , ,000 BE0182 F23.1 InVivoMab anti-mouse Vβ8 TCR mouse IgG2a , ,000 BE0182 F23.1 InVivoMab anti-mouse Vβ8 TCR mouse IgG2a , ,000 BE0183 TER-119 InVivoMab anti-mouse Ter-119 rat IgG2b 1 15,000 22,000 BE0183 TER-119 InVivoMab anti-mouse Ter-119 rat IgG2b 5 55,000 77,000 BE0183 TER-119 InVivoMab anti-mouse Ter-119 rat IgG2b , ,000 BE0183 TER-119 InVivoMab anti-mouse Ter-119 rat IgG2b , ,000 BE0183 TER-119 InVivoMab anti-mouse Ter-119 rat IgG2b , ,000 BE0184 8C11 InVivoMab anti-human N-cadherin (CD325) mouse IgG1 1 15,000 22,000 BE0184 8C11 InVivoMab anti-human N-cadherin (CD325) mouse IgG1 5 55,000 77,000 BE0184 8C11 InVivoMab anti-human N-cadherin (CD325) mouse IgG , ,000 BE0184 8C11 InVivoMab anti-human N-cadherin (CD325) mouse IgG , ,000 BE0184 8C11 InVivoMab anti-human N-cadherin (CD325) mouse IgG , ,000 BE0185 2H5 InVivoMab anti-human/mouse, rat CCL2 (MCP-1) Armenian hamster IgG 1 15,000 22,000 BE0185 2H5 InVivoMab anti-human/mouse, rat CCL2 (MCP-1) Armenian hamster IgG 5 55,000 77,000 BE0185 2H5 InVivoMab anti-human/mouse, rat CCL2 (MCP-1) Armenian hamster IgG , ,000 BE0185 2H5 InVivoMab anti-human/mouse, rat CCL2 (MCP-1) Armenian hamster IgG , ,000 BE0185 2H5 InVivoMab anti-human/mouse, rat CCL2 (MCP-1) Armenian hamster IgG , ,000 BE0186 4RA10 InVivoMab anti-mouse PSGL-1 (CD162) rat IgG1 1 15,000 22,000 BE0186 4RA10 InVivoMab anti-mouse PSGL-1 (CD162) rat IgG1 5 55,000 77,000 BE0186 4RA10 InVivoMab anti-mouse PSGL-1 (CD162) rat IgG , ,000 BE0186 4RA10 InVivoMab anti-mouse PSGL-1 (CD162) rat IgG , ,000 BE0186 4RA10 InVivoMab anti-mouse PSGL-1 (CD162) rat IgG , ,000 BE0187 3H5 InVivoMab anti-rat CD80 mouse IgG1 1 15,000 22,000 BE0187 3H5 InVivoMab anti-rat CD80 mouse IgG1 5 55,000 77,000 BE0187 3H5 InVivoMab anti-rat CD80 mouse IgG , ,000 BE0187 3H5 InVivoMab anti-rat CD80 mouse IgG , ,000 BE0187 3H5 InVivoMab anti-rat CD80 mouse IgG , ,000 BE0188 J116 InVivoMab anti-human PD-1 (CD279) mouse IgG1 1 15,000 22,000 BE0188 J116 InVivoMab anti-human PD-1 (CD279) mouse IgG1 5 55,000 77,000 BE0188 J116 InVivoMab anti-human PD-1 (CD279) mouse IgG , ,000 BE0188 J116 InVivoMab anti-human PD-1 (CD279) mouse IgG , ,000 BE0188 J116 InVivoMab anti-human PD-1 (CD279) mouse IgG , ,000 BE0189 G28.5 InVivoMab anti-human CD40 mouse IgG1 1 15,000 22,000 BE0189 G28.5 InVivoMab anti-human CD40 mouse IgG1 5 55,000 77,000 BE0189 G28.5 InVivoMab anti-human CD40 mouse IgG , ,000 BE0189 G28.5 InVivoMab anti-human CD40 mouse IgG , ,000 BE0189 G28.5 InVivoMab anti-human CD40 mouse IgG , ,000 BE0190 BN13 InVivoMab anti-human CTLA-4 (CD152) mouse IgG2a 1 15,000 22,000 BE0190 BN13 InVivoMab anti-human CTLA-4 (CD152) mouse IgG2a 5 55,000 77,000 BE0190 BN13 InVivoMab anti-human CTLA-4 (CD152) mouse IgG2a , ,000 BE0190 BN13 InVivoMab anti-human CTLA-4 (CD152) mouse IgG2a , ,000 BE0190 BN13 InVivoMab anti-human CTLA-4 (CD152) mouse IgG2a , ,000 BE0191 IK22/5 InVivoMab anti-mouse RANKL (CD254) rat IgG2a 1 15,000 22,000 BE0191 IK22/5 InVivoMab anti-mouse RANKL (CD254) rat IgG2a 5 55,000 77,000 BE0191 IK22/5 InVivoMab anti-mouse RANKL (CD254) rat IgG2a , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
15 BE0191 IK22/5 InVivoMab anti-mouse RANKL (CD254) rat IgG2a , ,000 BE0191 IK22/5 InVivoMab anti-mouse RANKL (CD254) rat IgG2a , ,000 BE0192 R7-1 InVivoMab anti-human CD11a (LFA-1α) mouse IgG1 1 15,000 22,000 BE0192 R7-1 InVivoMab anti-human CD11a (LFA-1α) mouse IgG1 5 55,000 77,000 BE0192 R7-1 InVivoMab anti-human CD11a (LFA-1α) mouse IgG , ,000 BE0192 R7-1 InVivoMab anti-human CD11a (LFA-1α) mouse IgG , ,000 BE0192 R7-1 InVivoMab anti-human CD11a (LFA-1α) mouse IgG , ,000 BE0193 J110 InVivoMab anti-human PD-1 (CD279) mouse IgG1 1 15,000 22,000 BE0193 J110 InVivoMab anti-human PD-1 (CD279) mouse IgG1 5 55,000 77,000 BE0193 J110 InVivoMab anti-human PD-1 (CD279) mouse IgG , ,000 BE0193 J110 InVivoMab anti-human PD-1 (CD279) mouse IgG , ,000 BE0193 J110 InVivoMab anti-human PD-1 (CD279) mouse IgG , ,000 BE0194 4G10 InVivoMab anti-phosphotyrosine mouse IgG2b 1 15,000 22,000 BE0194 4G10 InVivoMab anti-phosphotyrosine mouse IgG2b 5 55,000 77,000 BE0194 4G10 InVivoMab anti-phosphotyrosine mouse IgG2b , ,000 BE0194 4G10 InVivoMab anti-phosphotyrosine mouse IgG2b , ,000 BE0194 4G10 InVivoMab anti-phosphotyrosine mouse IgG2b , ,000 BE0196 PJ196 InVivoMab anti-mouse BTLA (CD272) mouse IgG1 1 15,000 22,000 BE0196 PJ196 InVivoMab anti-mouse BTLA (CD272) mouse IgG1 5 55,000 77,000 BE0196 PJ196 InVivoMab anti-mouse BTLA (CD272) mouse IgG , ,000 BE0196 PJ196 InVivoMab anti-mouse BTLA (CD272) mouse IgG , ,000 BE0196 PJ196 InVivoMab anti-mouse BTLA (CD272) mouse IgG , ,000 BE0198 TRFK5 InVivoMab anti-mouse/human IL-5 rat IgG1 1 15,000 22,000 BE0198 TRFK5 InVivoMab anti-mouse/human IL-5 rat IgG1 5 55,000 77,000 BE0198 TRFK5 InVivoMab anti-mouse/human IL-5 rat IgG , ,000 BE0198 TRFK5 InVivoMab anti-mouse/human IL-5 rat IgG , ,000 BE0198 TRFK5 InVivoMab anti-mouse/human IL-5 rat IgG , ,000 BE0199 BVD6-24G2 InVivoMab anti-mouse IL-4 rat IgG1 1 15,000 22,000 BE0199 BVD6-24G2 InVivoMab anti-mouse IL-4 rat IgG1 5 55,000 77,000 BE0199 BVD6-24G2 InVivoMab anti-mouse IL-4 rat IgG , ,000 BE0199 BVD6-24G2 InVivoMab anti-mouse IL-4 rat IgG , ,000 BE0199 BVD6-24G2 InVivoMab anti-mouse IL-4 rat IgG , ,000 InVivoMab anti-mouse Pan-endothelial Cell Antigen BE0200 MECA-32 (MECA-32) rat IgG2a 1 15,000 22,000 InVivoMab anti-mouse Pan-endothelial Cell Antigen BE0200 MECA-32 (MECA-32) rat IgG2a 5 55,000 77,000 InVivoMab anti-mouse Pan-endothelial Cell Antigen BE0200 MECA-32 (MECA-32) rat IgG2a , ,000 InVivoMab anti-mouse Pan-endothelial Cell Antigen BE0200 MECA-32 (MECA-32) rat IgG2a , ,000 InVivoMab anti-mouse Pan-endothelial Cell Antigen BE0200 MECA-32 (MECA-32) rat IgG2a , ,000 BE0201 2F1 InVivoMab anti-mouse/human KLRG-1 Syrian hamster IgG 1 15,000 22,000 BE0201 2F1 InVivoMab anti-mouse/human KLRG-1 Syrian hamster IgG 5 55,000 77,000 BE0201 2F1 InVivoMab anti-mouse/human KLRG-1 Syrian hamster IgG , ,000 BE0201 2F1 InVivoMab anti-mouse/human KLRG-1 Syrian hamster IgG , ,000 BE0201 2F1 InVivoMab anti-mouse/human KLRG-1 Syrian hamster IgG , ,000 BE c InVivoMab anti-mouse Siglec-H rat IgG2b 1 15,000 22,000 BE c InVivoMab anti-mouse Siglec-H rat IgG2b 5 55,000 77,000 BE c InVivoMab anti-mouse Siglec-H rat IgG2b , ,000 BE c InVivoMab anti-mouse Siglec-H rat IgG2b , ,000 BE c InVivoMab anti-mouse Siglec-H rat IgG2b , ,000 BE0203 MONTS-1 InVivoMab anti-mouse Ly6C rat IgG2a 1 15,000 22,000 BE0203 MONTS-1 InVivoMab anti-mouse Ly6C rat IgG2a 5 55,000 77,000 BE0203 MONTS-1 InVivoMab anti-mouse Ly6C rat IgG2a , ,000 BE0203 MONTS-1 InVivoMab anti-mouse Ly6C rat IgG2a , ,000 BE0203 MONTS-1 InVivoMab anti-mouse Ly6C rat IgG2a , ,000 BE0204 5A1 InVivoMab anti-mouse CSF1 rat IgG1 1 15,000 22,000 BE0204 5A1 InVivoMab anti-mouse CSF1 rat IgG1 5 55,000 77,000 BE0204 5A1 InVivoMab anti-mouse CSF1 rat IgG , ,000 BE0204 5A1 InVivoMab anti-mouse CSF1 rat IgG , ,000 BE0204 5A1 InVivoMab anti-mouse CSF1 rat IgG , ,000 BE0206 CI:A3-1 InVivoMab anti-mouse F4/80 rat IgG2b 1 15,000 22,000 BE0206 CI:A3-1 InVivoMab anti-mouse F4/80 rat IgG2b 5 55,000 77, ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
16 BE0206 CI:A3-1 InVivoMab anti-mouse F4/80 rat IgG2b , ,000 BE0206 CI:A3-1 InVivoMab anti-mouse F4/80 rat IgG2b , ,000 BE0206 CI:A3-1 InVivoMab anti-mouse F4/80 rat IgG2b , ,000 InVivoMab anti-mouse MHC Class I (H-2Kb) bound to BE D1.16 SIINFEKL peptide (OVA residues ) mouse IgG1 1 15,000 22,000 InVivoMab anti-mouse MHC Class I (H-2Kb) bound to BE D1.16 SIINFEKL peptide (OVA residues ) mouse IgG1 5 55,000 77,000 InVivoMab anti-mouse MHC Class I (H-2Kb) bound to BE D1.16 SIINFEKL peptide (OVA residues ) mouse IgG , ,000 InVivoMab anti-mouse MHC Class I (H-2Kb) bound to BE D1.16 SIINFEKL peptide (OVA residues ) mouse IgG , ,000 InVivoMab anti-mouse MHC Class I (H-2Kb) bound to BE D1.16 SIINFEKL peptide (OVA residues ) mouse IgG , ,000 BE0209 TY/23 InVivoMab anti-mouse CD73 rat IgG2a 1 15,000 22,000 BE0209 TY/23 InVivoMab anti-mouse CD73 rat IgG2a 5 55,000 77,000 BE0209 TY/23 InVivoMab anti-mouse CD73 rat IgG2a , ,000 BE0209 TY/23 InVivoMab anti-mouse CD73 rat IgG2a , ,000 BE0209 TY/23 InVivoMab anti-mouse CD73 rat IgG2a , ,000 BE0210 8F4 InVivoMab anti-mouse BTLA (CD272) mouse IgG1 1 15,000 22,000 BE0210 8F4 InVivoMab anti-mouse BTLA (CD272) mouse IgG1 5 55,000 77,000 BE0210 8F4 InVivoMab anti-mouse BTLA (CD272) mouse IgG , ,000 BE0210 8F4 InVivoMab anti-mouse BTLA (CD272) mouse IgG , ,000 BE0210 8F4 InVivoMab anti-mouse BTLA (CD272) mouse IgG , ,000 BE0211 OKT-6 InVivoMab anti-human CD1a mouse IgG1 1 15,000 22,000 BE0211 OKT-6 InVivoMab anti-human CD1a mouse IgG1 5 55,000 77,000 BE0211 OKT-6 InVivoMab anti-human CD1a mouse IgG , ,000 BE0211 OKT-6 InVivoMab anti-human CD1a mouse IgG , ,000 BE0211 OKT-6 InVivoMab anti-human CD1a mouse IgG , ,000 BE0212 T24/31 InVivoMab anti-mouse Thy1 (CD90) rat IgG2b 1 15,000 22,000 BE0212 T24/31 InVivoMab anti-mouse Thy1 (CD90) rat IgG2b 5 55,000 77,000 BE0212 T24/31 InVivoMab anti-mouse Thy1 (CD90) rat IgG2b , ,000 BE0212 T24/31 InVivoMab anti-mouse Thy1 (CD90) rat IgG2b , ,000 BE0212 T24/31 InVivoMab anti-mouse Thy1 (CD90) rat IgG2b , ,000 BE0213 AFS98 InVivoMab anti-mouse CSF1R (CD115) rat IgG2a 1 15,000 22,000 BE0213 AFS98 InVivoMab anti-mouse CSF1R (CD115) rat IgG2a 5 55,000 77,000 BE0213 AFS98 InVivoMab anti-mouse CSF1R (CD115) rat IgG2a , ,000 BE0213 AFS98 InVivoMab anti-mouse CSF1R (CD115) rat IgG2a , ,000 BE0213 AFS98 InVivoMab anti-mouse CSF1R (CD115) rat IgG2a , ,000 BE E12 InVivoMab anti-mouse Thy1.1 (CD90.1) mouse IgG2a 1 15,000 22,000 BE E12 InVivoMab anti-mouse Thy1.1 (CD90.1) mouse IgG2a 5 55,000 77,000 BE E12 InVivoMab anti-mouse Thy1.1 (CD90.1) mouse IgG2a , ,000 BE E12 InVivoMab anti-mouse Thy1.1 (CD90.1) mouse IgG2a , ,000 BE E12 InVivoMab anti-mouse Thy1.1 (CD90.1) mouse IgG2a , ,000 BE A3 InVivoMab anti-human YB-1 mouse IgG1 1 15,000 22,000 BE A3 InVivoMab anti-human YB-1 mouse IgG1 5 55,000 77,000 BE A3 InVivoMab anti-human YB-1 mouse IgG , ,000 BE A3 InVivoMab anti-human YB-1 mouse IgG , ,000 BE A3 InVivoMab anti-human YB-1 mouse IgG , ,000 BE0218 RG9-1 InVivoMab anti-mouse Galectin-9 rat IgG2b 1 15,000 22,000 BE0218 RG9-1 InVivoMab anti-mouse Galectin-9 rat IgG2b 5 55,000 77,000 BE0218 RG9-1 InVivoMab anti-mouse Galectin-9 rat IgG2b , ,000 BE0218 RG9-1 InVivoMab anti-mouse Galectin-9 rat IgG2b , ,000 BE0218 RG9-1 InVivoMab anti-mouse Galectin-9 rat IgG2b , ,000 BE InVivoMab anti-mouse MHC Class II (I-Ab, I-Ad) mouse IgM 1 15,000 22,000 BE InVivoMab anti-mouse MHC Class II (I-Ab, I-Ad) mouse IgM 5 55,000 77,000 BE InVivoMab anti-mouse MHC Class II (I-Ab, I-Ad) mouse IgM , ,000 BE InVivoMab anti-mouse MHC Class II (I-Ab, I-Ad) mouse IgM , ,000 BE InVivoMab anti-mouse MHC Class II (I-Ab, I-Ad) mouse IgM , ,000 BE D1 InVivoMab anti-mouse CD209b (SIGN-R1) Armenian hamster IgG 1 15,000 22,000 BE D1 InVivoMab anti-mouse CD209b (SIGN-R1) Armenian hamster IgG 5 55,000 77,000 BE D1 InVivoMab anti-mouse CD209b (SIGN-R1) Armenian hamster IgG , ,000 BE D1 InVivoMab anti-mouse CD209b (SIGN-R1) Armenian hamster IgG , ,000 BE D1 InVivoMab anti-mouse CD209b (SIGN-R1) Armenian hamster IgG , ,000 BE0222 1G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG1 1 15,000 22, ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
17 BE0222 1G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG1 5 55,000 77,000 BE0222 1G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG , ,000 BE0222 1G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG , ,000 BE0222 1G3 InVivoMab anti-rat FcRn heavy chain heterodimers mouse IgG , ,000 BE InVivoMab anti-mouse CD8β (Lyt 3.2) rat IgG1 1 15,000 22,000 BE InVivoMab anti-mouse CD8β (Lyt 3.2) rat IgG1 5 55,000 77,000 BE InVivoMab anti-mouse CD8β (Lyt 3.2) rat IgG , ,000 BE InVivoMab anti-mouse CD8β (Lyt 3.2) rat IgG , ,000 BE InVivoMab anti-mouse CD8β (Lyt 3.2) rat IgG , ,000 BE0224 IV.3 InVivoMab anti-human CD32 (FcγRIIA) mouse IgG2b 1 15,000 22,000 BE0224 IV.3 InVivoMab anti-human CD32 (FcγRIIA) mouse IgG2b 5 55,000 77,000 BE0224 IV.3 InVivoMab anti-human CD32 (FcγRIIA) mouse IgG2b , ,000 BE0224 IV.3 InVivoMab anti-human CD32 (FcγRIIA) mouse IgG2b , ,000 BE0224 IV.3 InVivoMab anti-human CD32 (FcγRIIA) mouse IgG2b , ,000 BE0225 RMT4-54 InVivoMab anti-mouse TIM-4 rat IgG2a 1 15,000 22,000 BE0225 RMT4-54 InVivoMab anti-mouse TIM-4 rat IgG2a 5 55,000 77,000 BE0225 RMT4-54 InVivoMab anti-mouse TIM-4 rat IgG2a , ,000 BE0225 RMT4-54 InVivoMab anti-mouse TIM-4 rat IgG2a , ,000 BE0225 RMT4-54 InVivoMab anti-mouse TIM-4 rat IgG2a , ,000 BE A12 InVivoMab anti-mouse ICOS Syrian hamster IgM 1 15,000 22,000 BE A12 InVivoMab anti-mouse ICOS Syrian hamster IgM 5 55,000 77,000 BE A12 InVivoMab anti-mouse ICOS Syrian hamster IgM , ,000 BE A12 InVivoMab anti-mouse ICOS Syrian hamster IgM , ,000 BE A12 InVivoMab anti-mouse ICOS Syrian hamster IgM , ,000 BE0227 J11d InVivoMab anti-mouse CD24 rat IgM 1 15,000 22,000 BE0227 J11d InVivoMab anti-mouse CD24 rat IgM 5 55,000 77,000 BE0227 J11d InVivoMab anti-mouse CD24 rat IgM , ,000 BE0227 J11d InVivoMab anti-mouse CD24 rat IgM , ,000 BE0227 J11d InVivoMab anti-mouse CD24 rat IgM , ,000 BE N (HB14) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a 1 15,000 22,000 BE N (HB14) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a 5 55,000 77,000 BE N (HB14) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a , ,000 BE N (HB14) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a , ,000 BE N (HB14) InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk) mouse IgG2a , ,000 InVivoMab anti-mouse MHC Class I (H-2Dk, H-2Kd, H- BE S (HB24) 2Kf) mouse IgG2a 1 15,000 22,000 InVivoMab anti-mouse MHC Class I (H-2Dk, H-2Kd, H- BE S (HB24) 2Kf) mouse IgG2a 5 55,000 77,000 InVivoMab anti-mouse MHC Class I (H-2Dk, H-2Kd, H- BE S (HB24) 2Kf) mouse IgG2a , ,000 InVivoMab anti-mouse MHC Class I (H-2Dk, H-2Kd, H- BE S (HB24) 2Kf) mouse IgG2a , ,000 InVivoMab anti-mouse MHC Class I (H-2Dk, H-2Kd, H- BE S (HB24) 2Kf) mouse IgG2a , ,000 BE0231 UCHT1 (Leu-4)(T3) InVivoMab anti-human CD3 mouse IgG1 1 15,000 22,000 BE0231 UCHT1 (Leu-4)(T3) InVivoMab anti-human CD3 mouse IgG1 5 55,000 77,000 BE0231 UCHT1 (Leu-4)(T3) InVivoMab anti-human CD3 mouse IgG , ,000 BE0231 UCHT1 (Leu-4)(T3) InVivoMab anti-human CD3 mouse IgG , ,000 BE0231 UCHT1 (Leu-4)(T3) InVivoMab anti-human CD3 mouse IgG , ,000 BE0232 KMI6 InVivoMab anti-mouse CD29 rat IgG2a 1 15,000 22,000 BE0232 KMI6 InVivoMab anti-mouse CD29 rat IgG2a 5 55,000 77,000 BE0232 KMI6 InVivoMab anti-mouse CD29 rat IgG2a , ,000 BE0232 KMI6 InVivoMab anti-mouse CD29 rat IgG2a , ,000 BE0232 KMI6 InVivoMab anti-mouse CD29 rat IgG2a , ,000 BE0233 R2-9A5 InVivoMab anti-mouse IL-12 p75 rat IgG2b 1 15,000 22,000 BE0233 R2-9A5 InVivoMab anti-mouse IL-12 p75 rat IgG2b 5 55,000 77,000 BE0233 R2-9A5 InVivoMab anti-mouse IL-12 p75 rat IgG2b , ,000 BE0233 R2-9A5 InVivoMab anti-mouse IL-12 p75 rat IgG2b , ,000 BE0233 R2-9A5 InVivoMab anti-mouse IL-12 p75 rat IgG2b , ,000 BE C2 InVivoMab anti-human IL-12 p70 rat IgG1 1 15,000 22,000 BE C2 InVivoMab anti-human IL-12 p70 rat IgG1 5 55,000 77,000 BE C2 InVivoMab anti-human IL-12 p70 rat IgG , ,000 BE C2 InVivoMab anti-human IL-12 p70 rat IgG , ,000 BE C2 InVivoMab anti-human IL-12 p70 rat IgG , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
18 BE0235 B133.5 InVivoMab anti-human IFNγ mouse IgG1 1 15,000 22,000 BE0235 B133.5 InVivoMab anti-human IFNγ mouse IgG1 5 55,000 77,000 BE0235 B133.5 InVivoMab anti-human IFNγ mouse IgG , ,000 BE0235 B133.5 InVivoMab anti-human IFNγ mouse IgG , ,000 BE0235 B133.5 InVivoMab anti-human IFNγ mouse IgG , ,000 BE InVivoMab anti-mouse Podoplanin (gp38) Syrian hamster IgG 1 15,000 22,000 BE InVivoMab anti-mouse Podoplanin (gp38) Syrian hamster IgG 5 55,000 77,000 BE InVivoMab anti-mouse Podoplanin (gp38) Syrian hamster IgG , ,000 BE InVivoMab anti-mouse Podoplanin (gp38) Syrian hamster IgG , ,000 BE InVivoMab anti-mouse Podoplanin (gp38) Syrian hamster IgG , ,000 BE0237 YIGIF74-1G7 InVivoMab anti-mouse IL-18 rat IgG2a 1 15,000 22,000 BE0237 YIGIF74-1G7 InVivoMab anti-mouse IL-18 rat IgG2a 5 55,000 77,000 BE0237 YIGIF74-1G7 InVivoMab anti-mouse IL-18 rat IgG2a , ,000 BE0237 YIGIF74-1G7 InVivoMab anti-mouse IL-18 rat IgG2a , ,000 BE0237 YIGIF74-1G7 InVivoMab anti-mouse IL-18 rat IgG2a , ,000 BE0238 9E10 InVivoMab anti-human c-myc mouse IgG1 1 15,000 22,000 BE0238 9E10 InVivoMab anti-human c-myc mouse IgG1 5 55,000 77,000 BE0238 9E10 InVivoMab anti-human c-myc mouse IgG , ,000 BE0238 9E10 InVivoMab anti-human c-myc mouse IgG , ,000 BE0238 9E10 InVivoMab anti-human c-myc mouse IgG , ,000 BE0239 3H3 InVivoMab anti-mouse CD137 (4-1BB) rat IgG2a 1 15,000 22,000 BE0239 3H3 InVivoMab anti-mouse CD137 (4-1BB) rat IgG2a 5 55,000 77,000 BE0239 3H3 InVivoMab anti-mouse CD137 (4-1BB) rat IgG2a , ,000 BE0239 3H3 InVivoMab anti-mouse CD137 (4-1BB) rat IgG2a , ,000 BE0239 3H3 InVivoMab anti-mouse CD137 (4-1BB) rat IgG2a , ,000 BE0240 MP4-25D2 InVivoMab anti-human IL-4 rat IgG1 1 15,000 22,000 BE0240 MP4-25D2 InVivoMab anti-human IL-4 rat IgG1 5 55,000 77,000 BE0240 MP4-25D2 InVivoMab anti-human IL-4 rat IgG , ,000 BE0240 MP4-25D2 InVivoMab anti-human IL-4 rat IgG , ,000 BE0240 MP4-25D2 InVivoMab anti-human IL-4 rat IgG , ,000 BE0241 MAR1-5A3 InVivoMab anti-mouse IFNAR-1 mouse IgG1 1 15,000 22,000 BE0241 MAR1-5A3 InVivoMab anti-mouse IFNAR-1 mouse IgG1 5 55,000 77,000 BE0241 MAR1-5A3 InVivoMab anti-mouse IFNAR-1 mouse IgG , ,000 BE0241 MAR1-5A3 InVivoMab anti-mouse IFNAR-1 mouse IgG , ,000 BE0241 MAR1-5A3 InVivoMab anti-mouse IFNAR-1 mouse IgG , ,000 BE0243 ALF-161 InVivoMab anti-mouse IL-1α Armenian hamster IgG 1 15,000 22,000 BE0243 ALF-161 InVivoMab anti-mouse IL-1α Armenian hamster IgG 5 55,000 77,000 BE0243 ALF-161 InVivoMab anti-mouse IL-1α Armenian hamster IgG , ,000 BE0243 ALF-161 InVivoMab anti-mouse IL-1α Armenian hamster IgG , ,000 BE0243 ALF-161 InVivoMab anti-mouse IL-1α Armenian hamster IgG , ,000 BE0244 TN InVivoMab anti-mouse/rat/rabbit TNFα Armenian hamster IgG 1 15,000 22,000 BE0244 TN InVivoMab anti-mouse/rat/rabbit TNFα Armenian hamster IgG 5 55,000 77,000 BE0244 TN InVivoMab anti-mouse/rat/rabbit TNFα Armenian hamster IgG , ,000 BE0244 TN InVivoMab anti-mouse/rat/rabbit TNFα Armenian hamster IgG , ,000 BE0244 TN InVivoMab anti-mouse/rat/rabbit TNFα Armenian hamster IgG , ,000 BE0245 B27 InVivoMab anti-human IFNγ mouse IgG1 1 15,000 22,000 BE0245 B27 InVivoMab anti-human IFNγ mouse IgG1 5 55,000 77,000 BE0245 B27 InVivoMab anti-human IFNγ mouse IgG , ,000 BE0245 B27 InVivoMab anti-human IFNγ mouse IgG , ,000 BE0245 B27 InVivoMab anti-human IFNγ mouse IgG , ,000 BE0246 B122 InVivoMab anti-mouse/rat IL-1β Armenian hamster IgG 1 15,000 22,000 BE0246 B122 InVivoMab anti-mouse/rat IL-1β Armenian hamster IgG 5 55,000 77,000 BE0246 B122 InVivoMab anti-mouse/rat IL-1β Armenian hamster IgG , ,000 BE0246 B122 InVivoMab anti-mouse/rat IL-1β Armenian hamster IgG , ,000 BE0246 B122 InVivoMab anti-mouse/rat IL-1β Armenian hamster IgG , ,000 BE0247 TR InVivoMab anti-mouse TNFR2 (CD120b) Armenian hamster IgG 1 15,000 22,000 BE0247 TR InVivoMab anti-mouse TNFR2 (CD120b) Armenian hamster IgG 5 55,000 77,000 BE0247 TR InVivoMab anti-mouse TNFR2 (CD120b) Armenian hamster IgG , ,000 BE0247 TR InVivoMab anti-mouse TNFR2 (CD120b) Armenian hamster IgG , ,000 BE0247 TR InVivoMab anti-mouse TNFR2 (CD120b) Armenian hamster IgG , ,000 BE InVivoMab anti-human CD28 mouse IgG2a 1 15,000 22,000 BE InVivoMab anti-human CD28 mouse IgG2a 5 55,000 77,000 BE InVivoMab anti-human CD28 mouse IgG2a , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
19 BE InVivoMab anti-human CD28 mouse IgG2a , ,000 BE InVivoMab anti-human CD28 mouse IgG2a , ,000 BE0249 CXCR3-173 InVivoMab anti-mouse CXCR3 (CD183) Armenian hamster IgG 1 15,000 22,000 BE0249 CXCR3-173 InVivoMab anti-mouse CXCR3 (CD183) Armenian hamster IgG 5 55,000 77,000 BE0249 CXCR3-173 InVivoMab anti-mouse CXCR3 (CD183) Armenian hamster IgG , ,000 BE0249 CXCR3-173 InVivoMab anti-mouse CXCR3 (CD183) Armenian hamster IgG , ,000 BE0249 CXCR3-173 InVivoMab anti-mouse CXCR3 (CD183) Armenian hamster IgG , ,000 BE0250 RG11/39.4 InVivoMab anti-rat IgG1 mouse IgG2a 1 15,000 22,000 BE0250 RG11/39.4 InVivoMab anti-rat IgG1 mouse IgG2a 5 55,000 77,000 BE0250 RG11/39.4 InVivoMab anti-rat IgG1 mouse IgG2a , ,000 BE0250 RG11/39.4 InVivoMab anti-rat IgG1 mouse IgG2a , ,000 BE0250 RG11/39.4 InVivoMab anti-rat IgG1 mouse IgG2a , ,000 BE0251 RG7/1.30 InVivoMab anti-rat IgG2a mouse IgG2b 1 15,000 22,000 BE0251 RG7/1.30 InVivoMab anti-rat IgG2a mouse IgG2b 5 55,000 77,000 BE0251 RG7/1.30 InVivoMab anti-rat IgG2a mouse IgG2b , ,000 BE0251 RG7/1.30 InVivoMab anti-rat IgG2a mouse IgG2b , ,000 BE0251 RG7/1.30 InVivoMab anti-rat IgG2a mouse IgG2b , ,000 BE0252 RG7/11.1 InVivoMab anti-rat IgG2b mouse IgG2b 1 15,000 22,000 BE0252 RG7/11.1 InVivoMab anti-rat IgG2b mouse IgG2b 5 55,000 77,000 BE0252 RG7/11.1 InVivoMab anti-rat IgG2b mouse IgG2b , ,000 BE0252 RG7/11.1 InVivoMab anti-rat IgG2b mouse IgG2b , ,000 BE0252 RG7/11.1 InVivoMab anti-rat IgG2b mouse IgG2b , ,000 InVivoMab anti-mouse Reticular Fibroblasts and BE0253 ER-TR7 Reticular Fibres (ER-TR7) rat IgG2a 1 15,000 22,000 InVivoMab anti-mouse Reticular Fibroblasts and BE0253 ER-TR7 Reticular Fibres (ER-TR7) rat IgG2a 5 55,000 77,000 InVivoMab anti-mouse Reticular Fibroblasts and BE0253 ER-TR7 Reticular Fibres (ER-TR7) rat IgG2a , ,000 InVivoMab anti-mouse Reticular Fibroblasts and BE0253 ER-TR7 Reticular Fibres (ER-TR7) rat IgG2a , ,000 InVivoMab anti-mouse Reticular Fibroblasts and BE0253 ER-TR7 Reticular Fibres (ER-TR7) rat IgG2a , ,000 BE0256 JAMA-147 InVivoMab anti-mouse IL-1 R (CD121a) Armenian hamster IgG 1 15,000 22,000 BE0256 JAMA-147 InVivoMab anti-mouse IL-1 R (CD121a) Armenian hamster IgG 5 55,000 77,000 BE0256 JAMA-147 InVivoMab anti-mouse IL-1 R (CD121a) Armenian hamster IgG , ,000 BE0256 JAMA-147 InVivoMab anti-mouse IL-1 R (CD121a) Armenian hamster IgG , ,000 BE0256 JAMA-147 InVivoMab anti-mouse IL-1 R (CD121a) Armenian hamster IgG , ,000 BE InVivoMab anti-mouse TCR Vγ1.1/Cr4 Armenian hamster IgG 1 15,000 22,000 BE InVivoMab anti-mouse TCR Vγ1.1/Cr4 Armenian hamster IgG 5 55,000 77,000 BE InVivoMab anti-mouse TCR Vγ1.1/Cr4 Armenian hamster IgG , ,000 BE InVivoMab anti-mouse TCR Vγ1.1/Cr4 Armenian hamster IgG , ,000 BE InVivoMab anti-mouse TCR Vγ1.1/Cr4 Armenian hamster IgG , ,000 BE0258 4A9 InVivoMab anti-mouse IL-21R rat IgG2a 1 15,000 22,000 BE0258 4A9 InVivoMab anti-mouse IL-21R rat IgG2a 5 55,000 77,000 BE0258 4A9 InVivoMab anti-mouse IL-21R rat IgG2a , ,000 BE0258 4A9 InVivoMab anti-mouse IL-21R rat IgG2a , ,000 BE0258 4A9 InVivoMab anti-mouse IL-21R rat IgG2a , ,000 BE0259 MP1-22E9 InVivoMab anti-mouse GM-CSF rat IgG2a 1 15,000 22,000 BE0259 MP1-22E9 InVivoMab anti-mouse GM-CSF rat IgG2a 5 55,000 77,000 BE0259 MP1-22E9 InVivoMab anti-mouse GM-CSF rat IgG2a , ,000 BE0259 MP1-22E9 InVivoMab anti-mouse GM-CSF rat IgG2a , ,000 BE0259 MP1-22E9 InVivoMab anti-mouse GM-CSF rat IgG2a , ,000 BE0260 PIP InVivoMab Armenian hamster IgG Isotype control Armenian hamster IgG 1 15,000 22,000 BE0260 PIP InVivoMab Armenian hamster IgG Isotype control Armenian hamster IgG 5 55,000 77,000 BE0260 PIP InVivoMab Armenian hamster IgG Isotype control Armenian hamster IgG , ,000 BE0260 PIP InVivoMab Armenian hamster IgG Isotype control Armenian hamster IgG , ,000 BE0260 PIP InVivoMab Armenian hamster IgG Isotype control Armenian hamster IgG , ,000 BE0261 KT3 InVivoMab anti-mouse CD3ε rat IgG2a 1 15,000 22,000 BE0261 KT3 InVivoMab anti-mouse CD3ε rat IgG2a 5 55,000 77,000 BE0261 KT3 InVivoMab anti-mouse CD3ε rat IgG2a , ,000 BE0261 KT3 InVivoMab anti-mouse CD3ε rat IgG2a , ,000 BE0261 KT3 InVivoMab anti-mouse CD3ε rat IgG2a , ,000 BE0262 Hermes-1 InVivoMab anti-human CD44 rat IgG2a 1 15,000 22,000 BE0262 Hermes-1 InVivoMab anti-human CD44 rat IgG2a 5 55,000 77, ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
20 BE0262 Hermes-1 InVivoMab anti-human CD44 rat IgG2a , ,000 BE0262 Hermes-1 InVivoMab anti-human CD44 rat IgG2a , ,000 BE0262 Hermes-1 InVivoMab anti-human CD44 rat IgG2a , ,000 BE0270 MIAP301 InVivoMab anti-mouse CD47 (IAP) rat IgG2a, kappa 1 15,000 22,000 BE0270 MIAP301 InVivoMab anti-mouse CD47 (IAP) rat IgG2a, kappa 5 55,000 77,000 BE0270 MIAP301 InVivoMab anti-mouse CD47 (IAP) rat IgG2a, kappa , ,000 BE0270 MIAP301 InVivoMab anti-mouse CD47 (IAP) rat IgG2a, kappa , ,000 BE0270 MIAP301 InVivoMab anti-mouse CD47 (IAP) rat IgG2a, kappa , ,000 BE0271 3E12 InVivoMab anti-mouse CD132 (common γ chain) rat IgG2b 1 15,000 22,000 BE0271 3E12 InVivoMab anti-mouse CD132 (common γ chain) rat IgG2b 5 55,000 77,000 BE0271 3E12 InVivoMab anti-mouse CD132 (common γ chain) rat IgG2b , ,000 BE0271 3E12 InVivoMab anti-mouse CD132 (common γ chain) rat IgG2b , ,000 BE0271 3E12 InVivoMab anti-mouse CD132 (common γ chain) rat IgG2b , ,000 BE0272 5H4 InVivoMab anti-mouse CD122 (IL-2Rβ) rat IgG2a, kappa 1 15,000 22,000 BE0272 5H4 InVivoMab anti-mouse CD122 (IL-2Rβ) rat IgG2a, kappa 5 55,000 77,000 BE0272 5H4 InVivoMab anti-mouse CD122 (IL-2Rβ) rat IgG2a, kappa , ,000 BE0272 5H4 InVivoMab anti-mouse CD122 (IL-2Rβ) rat IgG2a, kappa , ,000 BE0272 5H4 InVivoMab anti-mouse CD122 (IL-2Rβ) rat IgG2a, kappa , ,000 BE F.1A12 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a, kappa 1 15,000 22,000 BE F.1A12 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a, kappa 5 55,000 77,000 BE F.1A12 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a, kappa , ,000 BE F.1A12 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a, kappa , ,000 BE F.1A12 InVivoMab anti-mouse PD-1 (CD279) rat IgG2a, kappa , ,000 BE0274 1G9 InVivoMab anti-mouse TIGIT mouse IgG1, kappa 1 15,000 22,000 BE0274 1G9 InVivoMab anti-mouse TIGIT mouse IgG1, kappa 5 55,000 77,000 BE0274 1G9 InVivoMab anti-mouse TIGIT mouse IgG1, kappa , ,000 BE0274 1G9 InVivoMab anti-mouse TIGIT mouse IgG1, kappa , ,000 BE0274 1G9 InVivoMab anti-mouse TIGIT mouse IgG1, kappa , ,000 BE0275 B8.2C12 InVivoMab anti-mouse TIM-3 (CD366) rat IgG1 1 15,000 22,000 BE0275 B8.2C12 InVivoMab anti-mouse TIM-3 (CD366) rat IgG1 5 55,000 77,000 BE0275 B8.2C12 InVivoMab anti-mouse TIM-3 (CD366) rat IgG , ,000 BE0275 B8.2C12 InVivoMab anti-mouse TIM-3 (CD366) rat IgG , ,000 BE0275 B8.2C12 InVivoMab anti-mouse TIM-3 (CD366) rat IgG , ,000 BE0276 2H7 InVivoMab anti-human/monkey CD20 mouse IgG2b 1 15,000 22,000 BE0276 2H7 InVivoMab anti-human/monkey CD20 mouse IgG2b 5 55,000 77,000 BE0276 2H7 InVivoMab anti-human/monkey CD20 mouse IgG2b , ,000 BE0276 2H7 InVivoMab anti-human/monkey CD20 mouse IgG2b , ,000 BE0276 2H7 InVivoMab anti-human/monkey CD20 mouse IgG2b , ,000 BE InVivoMab anti-human/rat HER2 (neu) mouse IgG2a 1 15,000 22,000 BE InVivoMab anti-human/rat HER2 (neu) mouse IgG2a 5 55,000 77,000 BE InVivoMab anti-human/rat HER2 (neu) mouse IgG2a , ,000 BE InVivoMab anti-human/rat HER2 (neu) mouse IgG2a , ,000 BE InVivoMab anti-human/rat HER2 (neu) mouse IgG2a , ,000 BE (HB-8508) InVivoMab anti-human EGFR mouse IgG1 1 15,000 22,000 BE (HB-8508) InVivoMab anti-human EGFR mouse IgG1 5 55,000 77,000 BE (HB-8508) InVivoMab anti-human EGFR mouse IgG , ,000 BE (HB-8508) InVivoMab anti-human EGFR mouse IgG , ,000 BE (HB-8508) InVivoMab anti-human EGFR mouse IgG , ,000 BE (HB-8509) InVivoMab anti-human EGFR mouse IgG2a 1 15,000 22,000 BE (HB-8509) InVivoMab anti-human EGFR mouse IgG2a 5 55,000 77,000 BE (HB-8509) InVivoMab anti-human EGFR mouse IgG2a , ,000 BE (HB-8509) InVivoMab anti-human EGFR mouse IgG2a , ,000 BE (HB-8509) InVivoMab anti-human EGFR mouse IgG2a , ,000 BE0280 2B8 InVivoMab anti-mouse c-kit (CD117) rat IgG2b 1 15,000 22,000 BE0280 2B8 InVivoMab anti-mouse c-kit (CD117) rat IgG2b 5 55,000 77,000 BE0280 2B8 InVivoMab anti-mouse c-kit (CD117) rat IgG2b , ,000 BE0280 2B8 InVivoMab anti-mouse c-kit (CD117) rat IgG2b , ,000 BE0280 2B8 InVivoMab anti-mouse c-kit (CD117) rat IgG2b , ,000 BE0281 4G7 InVivoMab anti-human CD19 mouse IgG1 1 15,000 22,000 BE0281 4G7 InVivoMab anti-human CD19 mouse IgG1 5 55,000 77,000 BE0281 4G7 InVivoMab anti-human CD19 mouse IgG , ,000 BE0281 4G7 InVivoMab anti-human CD19 mouse IgG , ,000 BE0281 4G7 InVivoMab anti-human CD19 mouse IgG , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
21 BE0282 MP2-8F8 InVivoMab anti-mouse IL-3 rat IgG1 1 15,000 22,000 BE0282 MP2-8F8 InVivoMab anti-mouse IL-3 rat IgG1 5 55,000 77,000 BE0282 MP2-8F8 InVivoMab anti-mouse IL-3 rat IgG , ,000 BE0282 MP2-8F8 InVivoMab anti-mouse IL-3 rat IgG , ,000 BE0282 MP2-8F8 InVivoMab anti-mouse IL-3 rat IgG , ,000 BE0283 MIAP410 InVivoMab anti-human/mouse/rat CD47 mouse IgG1 1 15,000 22,000 BE0283 MIAP410 InVivoMab anti-human/mouse/rat CD47 mouse IgG1 5 55,000 77,000 BE0283 MIAP410 InVivoMab anti-human/mouse/rat CD47 mouse IgG , ,000 BE0283 MIAP410 InVivoMab anti-human/mouse/rat CD47 mouse IgG , ,000 BE0283 MIAP410 InVivoMab anti-human/mouse/rat CD47 mouse IgG , ,000 BE0284 HK1.4 InVivoMab anti-mouse Ly6C rat IgG2c 1 15,000 22,000 BE0284 HK1.4 InVivoMab anti-mouse Ly6C rat IgG2c 5 55,000 77,000 BE0284 HK1.4 InVivoMab anti-mouse Ly6C rat IgG2c , ,000 BE0284 HK1.4 InVivoMab anti-mouse Ly6C rat IgG2c , ,000 BE0284 HK1.4 InVivoMab anti-mouse Ly6C rat IgG2c , ,000 BE E.2A3 InVivoMab anti-human PD-L1 (B7-H1) mouse IgG2b 1 15,000 22,000 BE E.2A3 InVivoMab anti-human PD-L1 (B7-H1) mouse IgG2b 5 55,000 77,000 BE E.2A3 InVivoMab anti-human PD-L1 (B7-H1) mouse IgG2b , ,000 BE E.2A3 InVivoMab anti-human PD-L1 (B7-H1) mouse IgG2b , ,000 BE E.2A3 InVivoMab anti-human PD-L1 (B7-H1) mouse IgG2b , ,000 BE0286 GIR-208 InVivoMab anti-human IFNγRα (CD119) mouse IgG1 1 15,000 22,000 BE0286 GIR-208 InVivoMab anti-human IFNγRα (CD119) mouse IgG1 5 55,000 77,000 BE0286 GIR-208 InVivoMab anti-human IFNγRα (CD119) mouse IgG , ,000 BE0286 GIR-208 InVivoMab anti-human IFNγRα (CD119) mouse IgG , ,000 BE0286 GIR-208 InVivoMab anti-human IFNγRα (CD119) mouse IgG , ,000 BE0287 2E2 InVivoMab anti-mouse IFNγRα (CD119) Armenian hamster IgG 1 15,000 22,000 BE0287 2E2 InVivoMab anti-mouse IFNγRα (CD119) Armenian hamster IgG 5 55,000 77,000 BE0287 2E2 InVivoMab anti-mouse IFNγRα (CD119) Armenian hamster IgG , ,000 BE0287 2E2 InVivoMab anti-mouse IFNγRα (CD119) Armenian hamster IgG , ,000 BE0287 2E2 InVivoMab anti-mouse IFNγRα (CD119) Armenian hamster IgG , ,000 BE0288 RPA-T4 InVivoMab anti-human CD4 mouse IgG1 1 15,000 22,000 BE0288 RPA-T4 InVivoMab anti-human CD4 mouse IgG1 5 55,000 77,000 BE0288 RPA-T4 InVivoMab anti-human CD4 mouse IgG , ,000 BE0288 RPA-T4 InVivoMab anti-human CD4 mouse IgG , ,000 BE0288 RPA-T4 InVivoMab anti-human CD4 mouse IgG , ,000 BE0289 3B3 InVivoMAb anti-mouse TIM-1 (CD365) rat IgG2a 1 15,000 22,000 BE0289 3B3 InVivoMAb anti-mouse TIM-1 (CD365) rat IgG2a 5 55,000 77,000 BE0289 3B3 InVivoMAb anti-mouse TIM-1 (CD365) rat IgG2a , ,000 BE0289 3B3 InVivoMAb anti-mouse TIM-1 (CD365) rat IgG2a , ,000 BE0289 3B3 InVivoMAb anti-mouse TIM-1 (CD365) rat IgG2a , ,000 BE0290 TNP6A7 InVivoMab rat IgG1 isotype control rat IgG1 1 15,000 22,000 BE0290 TNP6A7 InVivoMab rat IgG1 isotype control rat IgG1 5 55,000 77,000 BE0290 TNP6A7 InVivoMab rat IgG1 isotype control rat IgG , ,000 BE0290 TNP6A7 InVivoMab rat IgG1 isotype control rat IgG , ,000 BE0290 TNP6A7 InVivoMab rat IgG1 isotype control rat IgG , ,000 BE0291 CD28.2 InVivoMAb anti-human/monkey CD28 mouse IgG1 1 15,000 22,000 BE0291 CD28.2 InVivoMAb anti-human/monkey CD28 mouse IgG1 5 55,000 77,000 BE0291 CD28.2 InVivoMAb anti-human/monkey CD28 mouse IgG , ,000 BE0291 CD28.2 InVivoMAb anti-human/monkey CD28 mouse IgG , ,000 BE0291 CD28.2 InVivoMAb anti-human/monkey CD28 mouse IgG , ,000 BE0292 5C8 InVivoMAb anti-human/monkey CD40L (CD154) mouse IgG2a 1 15,000 22,000 BE0292 5C8 InVivoMAb anti-human/monkey CD40L (CD154) mouse IgG2a 5 55,000 77,000 BE0292 5C8 InVivoMAb anti-human/monkey CD40L (CD154) mouse IgG2a , ,000 BE0292 5C8 InVivoMAb anti-human/monkey CD40L (CD154) mouse IgG2a , ,000 BE0292 5C8 InVivoMAb anti-human/monkey CD40L (CD154) mouse IgG2a , ,000 BE0294 9A9 InVivoMAb anti-mouse E-selectin (CD62E) rat IgG2b 1 15,000 22,000 BE0294 9A9 InVivoMAb anti-mouse E-selectin (CD62E) rat IgG2b 5 55,000 77,000 BE0294 9A9 InVivoMAb anti-mouse E-selectin (CD62E) rat IgG2b , ,000 BE0294 9A9 InVivoMAb anti-mouse E-selectin (CD62E) rat IgG2b , ,000 BE0294 9A9 InVivoMAb anti-mouse E-selectin (CD62E) rat IgG2b , ,000 BE B5 InVivoMAb anti-mouse 4-1BB (CD137) Syrian hamster IgG 1 15,000 22,000 BE B5 InVivoMAb anti-mouse 4-1BB (CD137) Syrian hamster IgG 5 55,000 77,000 BE B5 InVivoMAb anti-mouse 4-1BB (CD137) Syrian hamster IgG , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
22 BE B5 InVivoMAb anti-mouse 4-1BB (CD137) Syrian hamster IgG , ,000 BE B5 InVivoMAb anti-mouse 4-1BB (CD137) Syrian hamster IgG , ,000 BE0297 n/a InVivoMAb human IgG1 isotype control human IgG1 1 15,000 22,000 BE0297 n/a InVivoMAb human IgG1 isotype control human IgG1 5 55,000 77,000 BE0297 n/a InVivoMAb human IgG1 isotype control human IgG , ,000 BE0297 n/a InVivoMAb human IgG1 isotype control human IgG , ,000 BE0297 n/a InVivoMAb human IgG1 isotype control human IgG , ,000 BE0298 TM-Beta 1 InVivoMAb anti-mouse CD122 (IL-2Rβ) rat IgG2b 1 15,000 22,000 BE0298 TM-Beta 1 InVivoMAb anti-mouse CD122 (IL-2Rβ) rat IgG2b 5 55,000 77,000 BE0298 TM-Beta 1 InVivoMAb anti-mouse CD122 (IL-2Rβ) rat IgG2b , ,000 BE0298 TM-Beta 1 InVivoMAb anti-mouse CD122 (IL-2Rβ) rat IgG2b , ,000 BE0298 TM-Beta 1 InVivoMAb anti-mouse CD122 (IL-2Rβ) rat IgG2b , ,000 BE0299 OX-90 InVivoMAb anti-mouse CD200 (OX2) rat IgG2a 1 15,000 22,000 BE0299 OX-90 InVivoMAb anti-mouse CD200 (OX2) rat IgG2a 5 55,000 77,000 BE0299 OX-90 InVivoMAb anti-mouse CD200 (OX2) rat IgG2a , ,000 BE0299 OX-90 InVivoMAb anti-mouse CD200 (OX2) rat IgG2a , ,000 BE0299 OX-90 InVivoMAb anti-mouse CD200 (OX2) rat IgG2a , ,000 BE InVivoMAb anti-mouse CD45.2 mouse IgG2a 1 15,000 22,000 BE InVivoMAb anti-mouse CD45.2 mouse IgG2a 5 55,000 77,000 BE InVivoMAb anti-mouse CD45.2 mouse IgG2a , ,000 BE InVivoMAb anti-mouse CD45.2 mouse IgG2a , ,000 BE InVivoMAb anti-mouse CD45.2 mouse IgG2a , ,000 BE0301 n/a InVivoMAb human IgG2 isotype control human IgG2 1 15,000 22,000 BE0301 n/a InVivoMAb human IgG2 isotype control human IgG2 5 55,000 77,000 BE0301 n/a InVivoMAb human IgG2 isotype control human IgG , ,000 BE0301 n/a InVivoMAb human IgG2 isotype control human IgG , ,000 BE0301 n/a InVivoMAb human IgG2 isotype control human IgG , ,000 BE0302 AISB12 InVivoMAb anti-mouse CD20 rat IgG2a , ,000 BE0302 AISB12 InVivoMAb anti-mouse CD20 rat IgG2a , ,000 BE0302 AISB12 InVivoMAb anti-mouse CD20 rat IgG2a , ,000 BE0303 MM17F8F5.1A9 InVivoMAb anti-mouse IL-17F mouse IgG1, κ 1 15,000 22,000 BE0303 MM17F8F5.1A9 InVivoMAb anti-mouse IL-17F mouse IgG1, κ 5 55,000 77,000 BE0303 MM17F8F5.1A9 InVivoMAb anti-mouse IL-17F mouse IgG1, κ , ,000 BE0303 MM17F8F5.1A9 InVivoMAb anti-mouse IL-17F mouse IgG1, κ , ,000 BE0303 MM17F8F5.1A9 InVivoMAb anti-mouse IL-17F mouse IgG1, κ , ,000 BE0304 6F7 InVivoMAb anti-mouse BTLA (CD272) mouse IgG1, κ 1 15,000 22,000 BE0304 6F7 InVivoMAb anti-mouse BTLA (CD272) mouse IgG1, κ 5 55,000 77,000 BE0304 6F7 InVivoMAb anti-mouse BTLA (CD272) mouse IgG1, κ , ,000 BE0304 6F7 InVivoMAb anti-mouse BTLA (CD272) mouse IgG1, κ , ,000 BE0304 6F7 InVivoMAb anti-mouse BTLA (CD272) mouse IgG1, κ , ,000 BE0305 7H11 InVivoMAb anti-mouse CLEC9A (CD370) Rat IgG1, κ 1 15,000 22,000 BE0305 7H11 InVivoMAb anti-mouse CLEC9A (CD370) Rat IgG1, κ 5 55,000 77,000 BE0305 7H11 InVivoMAb anti-mouse CLEC9A (CD370) Rat IgG1, κ , ,000 BE0305 7H11 InVivoMAb anti-mouse CLEC9A (CD370) Rat IgG1, κ , ,000 BE0305 7H11 InVivoMAb anti-mouse CLEC9A (CD370) Rat IgG1, κ , ,000 InVivoMAb anti-human/monkey MHC class II (HLA- Mouse IgG2a, κ BE0306 L243 DR) 1 15,000 22,000 InVivoMAb anti-human/monkey MHC class II (HLA- Mouse IgG2a, κ BE0306 L243 DR) 5 55,000 77,000 InVivoMAb anti-human/monkey MHC class II (HLA- Mouse IgG2a, κ BE0306 L243 DR) , ,000 InVivoMAb anti-human/monkey MHC class II (HLA- Mouse IgG2a, κ BE0306 L243 DR) , ,000 InVivoMAb anti-human/monkey MHC class II (HLA- Mouse IgG2a, κ BE0306 L243 DR) , ,000 BE G2 InVivoMAb anti-mouse CD16/CD32 Rat IgG2b, κ 5 55,000 77,000 BE G2 InVivoMAb anti-mouse CD16/CD32 Rat IgG2b, κ , ,000 BE G2 InVivoMAb anti-mouse CD16/CD32 Rat IgG2b, κ , ,000 BE G2 InVivoMAb anti-mouse CD16/CD32 Rat IgG2b, κ , ,000 BE0308 OX-38 InVivoMAb anti-rat CD4 Mouse IgG2a, κ 1 15,000 22,000 BE0308 OX-38 InVivoMAb anti-rat CD4 Mouse IgG2a, κ 5 55,000 77,000 BE0308 OX-38 InVivoMAb anti-rat CD4 Mouse IgG2a, κ , ,000 BE0308 OX-38 InVivoMAb anti-rat CD4 Mouse IgG2a, κ , ,000 BE0308 OX-38 InVivoMAb anti-rat CD4 Mouse IgG2a, κ , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
23 Bio X Cell 社価格表 (2018 年 4 月 ) < 株式会社シン コーポレーション > 品番クローン品名イソタイプ 容量 (mg) 大学向希望小売価格 ( 円 ) 税別 希望小売価格 ( 円 ) 税別 InVivoPlus シリーズ (mg) BP C11 InVivoPlus anti-mouse CD3ε Armenian hamster IgG 5 71, ,000 BP C11 InVivoPlus anti-mouse CD3ε Armenian hamster IgG , ,000 BP C11 InVivoPlus anti-mouse CD3ε Armenian hamster IgG , ,000 BP C11 InVivoPlus anti-mouse CD3ε Armenian hamster IgG , ,000 BP GK1.5 InVivoPlus anti-mouse CD4 rat IgG2b 5 71, ,000 BP GK1.5 InVivoPlus anti-mouse CD4 rat IgG2b , ,000 BP GK1.5 InVivoPlus anti-mouse CD4 rat IgG2b , ,000 BP GK1.5 InVivoPlus anti-mouse CD4 rat IgG2b , ,000 BP InVivoPlus anti-mouse CD8α rat IgG2a 5 71, ,000 BP InVivoPlus anti-mouse CD8α rat IgG2a , ,000 BP InVivoPlus anti-mouse CD8α rat IgG2a , ,000 BP InVivoPlus anti-mouse CD8α rat IgG2a , ,000 BP0012 PC InVivoPlus anti-mouse CD25 (IL-2Rα) rat IgG1 5 71, ,000 BP0012 PC InVivoPlus anti-mouse CD25 (IL-2Rα) rat IgG , ,000 BP0012 PC InVivoPlus anti-mouse CD25 (IL-2Rα) rat IgG , ,000 BP0012 PC InVivoPlus anti-mouse CD25 (IL-2Rα) rat IgG , ,000 BP FGK4.5/FGK45 InVivoPlus anti-mouse CD40 rat IgG2a 5 71, ,000 BP FGK4.5/FGK45 InVivoPlus anti-mouse CD40 rat IgG2a , ,000 BP FGK4.5/FGK45 InVivoPlus anti-mouse CD40 rat IgG2a , ,000 BP FGK4.5/FGK45 InVivoPlus anti-mouse CD40 rat IgG2a , ,000 BP MR-1 InVivoPlus anti-mouse CD154 (CD40L) Armenian hamster IgG 5 71, ,000 BP MR-1 InVivoPlus anti-mouse CD154 (CD40L) Armenian hamster IgG , ,000 BP MR-1 InVivoPlus anti-mouse CD154 (CD40L) Armenian hamster IgG , ,000 BP MR-1 InVivoPlus anti-mouse CD154 (CD40L) Armenian hamster IgG , ,000 BP0031 OX-86 InVivoPlus anti-mouse OX40 (CD134) rat IgG1 5 71, ,000 BP0031 OX-86 InVivoPlus anti-mouse OX40 (CD134) rat IgG , ,000 BP0031 OX-86 InVivoPlus anti-mouse OX40 (CD134) rat IgG , ,000 BP0031 OX-86 InVivoPlus anti-mouse OX40 (CD134) rat IgG , ,000 BP0032 UC10-4F10-12 InVivoPlus mouse CTLA-4 (CD152) Armenian hamster IgG 5 71, ,000 BP0032 UC10-4F10-13 InVivoPlus mouse CTLA-4 (CD152) Armenian hamster IgG , ,000 BP0032 UC10-4F10-14 InVivoPlus mouse CTLA-4 (CD152) Armenian hamster IgG , ,000 BP0032 UC10-4F10-11 InVivoPlus mouse CTLA-4 (CD152) Armenian hamster IgG , ,000 BP J43 InVivoPlus anti-mouse PD-1 (CD279) Armenian hamster IgG 5 71, ,000 BP J43 InVivoPlus anti-mouse PD-1 (CD279) Armenian hamster IgG , ,000 BP J43 InVivoPlus anti-mouse PD-1 (CD279) Armenian hamster IgG , ,000 BP J43 InVivoPlus anti-mouse PD-1 (CD279) Armenian hamster IgG , ,000 BP0036 PK136 InVivoPlus anti-mouse NK1.1 mouse IgG2a 5 71, ,000 BP0036 PK136 InVivoPlus anti-mouse NK1.1 mouse IgG2a , ,000 BP0036 PK136 InVivoPlus anti-mouse NK1.1 mouse IgG2a , ,000 BP0036 PK136 InVivoPlus anti-mouse NK1.1 mouse IgG2a , ,000 BP B11 InVivoPlus anti-mouse IL-4 rat IgG1 5 71, ,000 BP B11 InVivoPlus anti-mouse IL-4 rat IgG , ,000 BP B11 InVivoPlus anti-mouse IL-4 rat IgG , ,000 BP B11 InVivoPlus anti-mouse IL-4 rat IgG , ,000 BP0050 1B1.3A InVivoPlus anti-mouse IL-10R (CD210) rat IgG1 5 71, ,000 BP0050 1B1.3A InVivoPlus anti-mouse IL-10R (CD210) rat IgG , ,000 BP0050 1B1.3A InVivoPlus anti-mouse IL-10R (CD210) rat IgG , ,000 BP0050 1B1.3A InVivoPlus anti-mouse IL-10R (CD210) rat IgG , ,000 BP0051 C17.8 InVivoPlus anti-mouse IL-12 p40 rat IgG2a 5 71, ,000 BP0051 C17.8 InVivoPlus anti-mouse IL-12 p40 rat IgG2a , ,000 BP0051 C17.8 InVivoPlus anti-mouse IL-12 p40 rat IgG2a , ,000 BP0051 C17.8 InVivoPlus anti-mouse IL-12 p40 rat IgG2a , ,000 BP0055 XMG1.2 InVivoPlus anti-mouse IFNγ rat IgG1 5 71, ,000 BP0055 XMG1.2 InVivoPlus anti-mouse IFNγ rat IgG , ,000 BP0055 XMG1.2 InVivoPlus anti-mouse IFNγ rat IgG , ,000 BP0055 XMG1.2 InVivoPlus anti-mouse IFNγ rat IgG , ,000 InVivoPlus anti-mouse/human/rat/monkey/ BP0057 1D hamster/canine/bovine TGF-β mouse IgG1 5 71, ,000 InVivoPlus anti-mouse/human/rat/monkey/ BP0057 1D hamster/canine/bovine TGF-β mouse IgG , ,000 容量 大学向希望小売価格 ( 円 ) 税別 希望小売価格 ( 円 ) 税別 23 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
24 InVivoPlus anti-mouse/human/rat/monkey/ BP0057 1D hamster/canine/bovine TGF-β mouse IgG , ,000 InVivoPlus anti-mouse/human/rat/monkey/ BP0057 1D hamster/canine/bovine TGF-β mouse IgG , ,000 BP0058 XT3.11 InVivoPlus anti-mouse TNFα rat IgG1 5 71, ,000 BP0058 XT3.11 InVivoPlus anti-mouse TNFα rat IgG , ,000 BP0058 XT3.11 InVivoPlus anti-mouse TNFα rat IgG , ,000 BP0058 XT3.11 InVivoPlus anti-mouse TNFα rat IgG , ,000 BP0060 DC101 InVivoPlus anti-mouse VEGFR-2 rat IgG1 5 71, ,000 BP0060 DC101 InVivoPlus anti-mouse VEGFR-2 rat IgG , ,000 BP0060 DC101 InVivoPlus anti-mouse VEGFR-2 rat IgG , ,000 BP0060 DC101 InVivoPlus anti-mouse VEGFR-2 rat IgG , ,000 BP InVivoPlus anti-mouse CD8α rat IgG2b 5 71, ,000 BP InVivoPlus anti-mouse CD8α rat IgG2b , ,000 BP InVivoPlus anti-mouse CD8α rat IgG2b , ,000 BP InVivoPlus anti-mouse CD8α rat IgG2b , ,000 BP0063 DTA-1 InVivoPlus anti-mouse GITR rat IgG2b 5 71, ,000 BP0063 DTA-1 InVivoPlus anti-mouse GITR rat IgG2b , ,000 BP0063 DTA-1 InVivoPlus anti-mouse GITR rat IgG2b , ,000 BP0063 DTA-1 InVivoPlus anti-mouse GITR rat IgG2b , ,000 BP H12 InVivoPlus anti-mouse Thy1.2 (CD90.2) rat IgG2b 5 71, ,000 BP H12 InVivoPlus anti-mouse Thy1.2 (CD90.2) rat IgG2b , ,000 BP H12 InVivoPlus anti-mouse Thy1.2 (CD90.2) rat IgG2b , ,000 BP H12 InVivoPlus anti-mouse Thy1.2 (CD90.2) rat IgG2b , ,000 BP0075 RB6-8C5 InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b 5 71, ,000 BP0075 RB6-8C5 InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b , ,000 BP0075 RB6-8C5 InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b , ,000 BP0075 RB6-8C5 InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) rat IgG2b , ,000 BP A8 InVivoPlus anti-mouse Ly6G rat IgG2a 5 71, ,000 BP A8 InVivoPlus anti-mouse Ly6G rat IgG2a , ,000 BP A8 InVivoPlus anti-mouse Ly6G rat IgG2a , ,000 BP A8 InVivoPlus anti-mouse Ly6G rat IgG2a , ,000 BP0083 MOPC-21 InVivoPlus mouse IgG1 isotype control mouse IgG1 5 71, ,000 BP0083 MOPC-21 InVivoPlus mouse IgG1 isotype control mouse IgG , ,000 BP0083 MOPC-21 InVivoPlus mouse IgG1 isotype control mouse IgG , ,000 BP0083 MOPC-21 InVivoPlus mouse IgG1 isotype control mouse IgG , ,000 BP0085 C InVivoPlus mouse IgG2a isotype control mouse IgG2a 5 71, ,000 BP0085 C InVivoPlus mouse IgG2a isotype control mouse IgG2a , ,000 BP0085 C InVivoPlus mouse IgG2a isotype control mouse IgG2a , ,000 BP0085 C InVivoPlus mouse IgG2a isotype control mouse IgG2a , ,000 BP0086 MPC-11 InVivoPlus mouse IgG2b isotype control mouse IgG2b 5 71, ,000 BP0086 MPC-11 InVivoPlus mouse IgG2b isotype control mouse IgG2b , ,000 BP0086 MPC-11 InVivoPlus mouse IgG2b isotype control mouse IgG2b , ,000 BP0086 MPC-11 InVivoPlus mouse IgG2b isotype control mouse IgG2b , ,000 BP0087 Polyclonal Syrian InVivoPlus polyclonal Syrian hamster IgG Syrian hamster IgG 5 71, ,000 BP0087 Polyclonal Syrian InVivoPlus polyclonal Syrian hamster IgG Syrian hamster IgG , ,000 BP0087 Polyclonal Syrian InVivoPlus polyclonal Syrian hamster IgG Syrian hamster IgG , ,000 BP0087 Polyclonal Syrian InVivoPlus polyclonal Syrian hamster IgG Syrian hamster IgG , ,000 BP0088 HRPN InVivoPlus rat IgG1 isotype control (anti-hrp) rat IgG1 5 71, ,000 BP0088 HRPN InVivoPlus rat IgG1 isotype control (anti-hrp) rat IgG , ,000 BP0088 HRPN InVivoPlus rat IgG1 isotype control (anti-hrp) rat IgG , ,000 BP0088 HRPN InVivoPlus rat IgG1 isotype control (anti-hrp) rat IgG , ,000 BP0089 2A3 InVivoPlus rat IgG2a isotype control rat IgG2a 5 71, ,000 BP0089 2A3 InVivoPlus rat IgG2a isotype control rat IgG2a , ,000 BP0089 2A3 InVivoPlus rat IgG2a isotype control rat IgG2a , ,000 BP0089 2A3 InVivoPlus rat IgG2a isotype control rat IgG2a , ,000 BP0090 LTF-2 InVivoPlus rat IgG2b I sotype control rat IgG2b 5 71, ,000 BP0090 LTF-2 InVivoPlus rat IgG2b I sotype control rat IgG2b , ,000 BP0090 LTF-2 InVivoPlus rat IgG2b I sotype control rat IgG2b , ,000 BP0090 LTF-2 InVivoPlus rat IgG2b I sotype control rat IgG2b , ,000 BP0091 Polyclonal Armenian InVivoPlus polyclonal Armenian hamster IgG Armenian hamster IgG 5 71, ,000 BP0091 Polyclonal Armenian InVivoPlus polyclonal Armenian hamster IgG Armenian hamster IgG , ,000 BP0091 Polyclonal Armenian InVivoPlus polyclonal Armenian hamster IgG Armenian hamster IgG , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
25 BP0091 Polyclonal Armenian InVivoPlus polyclonal Armenian hamster IgG Armenian hamster IgG , ,000 BP0099 CTLA-4-Ig (hum./hum.) InVivoPlus recombinant CTLA-4-Ig (hum./hum.) human IgG 5 71, ,000 BP0099 CTLA-4-Ig (hum./hum.) InVivoPlus recombinant CTLA-4-Ig (hum./hum.) human IgG , ,000 BP0099 CTLA-4-Ig (hum./hum.) InVivoPlus recombinant CTLA-4-Ig (hum./hum.) human IgG , ,000 BP0099 CTLA-4-Ig (hum./hum.) InVivoPlus recombinant CTLA-4-Ig (hum./hum.) human IgG , ,000 BP F.9G2 InVivoPlus anti-mouse PD-L1 (B7-H1) rat IgG2b 5 71, ,000 BP F.9G2 InVivoPlus anti-mouse PD-L1 (B7-H1) rat IgG2b , ,000 BP F.9G2 InVivoPlus anti-mouse PD-L1 (B7-H1) rat IgG2b , ,000 BP F.9G2 InVivoPlus anti-mouse PD-L1 (B7-H1) rat IgG2b , ,000 BP0115 RMT3-23 InVivoPlus anti-mouse TIM-3 (CD366) rat IgG2a 5 71, ,000 BP0115 RMT3-23 InVivoPlus anti-mouse TIM-3 (CD366) rat IgG2a , ,000 BP0115 RMT3-23 InVivoPlus anti-mouse TIM-3 (CD366) rat IgG2a , ,000 BP0115 RMT3-23 InVivoPlus anti-mouse TIM-3 (CD366) rat IgG2a , ,000 BP0117 YTS169.4 InVivoPlus anti-mouse CD8α rat IgG2b 5 71, ,000 BP0117 YTS169.4 InVivoPlus anti-mouse CD8α rat IgG2b , ,000 BP0117 YTS169.4 InVivoPlus anti-mouse CD8α rat IgG2b , ,000 BP0117 YTS169.4 InVivoPlus anti-mouse CD8α rat IgG2b , ,000 BP0131 9H10 InVivoPlus anti-mouse CTLA-4 (CD152) Syrian hamster IgG2 5 71, ,000 BP0131 9H10 InVivoPlus anti-mouse CTLA-4 (CD152) Syrian hamster IgG , ,000 BP0131 9H10 InVivoPlus anti-mouse CTLA-4 (CD152) Syrian hamster IgG , ,000 BP0131 9H10 InVivoPlus anti-mouse CTLA-4 (CD152) Syrian hamster IgG , ,000 BP0146 RMP1-14 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a 5 71, ,000 BP0146 RMP1-14 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a , ,000 BP0146 RMP1-14 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a , ,000 BP0146 RMP1-14 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a , ,000 BP0164 9D9 InVivoPlus anti-mouse CTLA-4 (CD152) mouse IgG2b 5 71, ,000 BP0164 9D9 InVivoPlus anti-mouse CTLA-4 (CD152) mouse IgG2b , ,000 BP0164 9D9 InVivoPlus anti-mouse CTLA-4 (CD152) mouse IgG2b , ,000 BP0164 9D9 InVivoPlus anti-mouse CTLA-4 (CD152) mouse IgG2b , ,000 BP0169 LOB12.3 InVivoPlus anti-mouse 4-1BB (CD137) rat IgG2a 5 71, ,000 BP0169 LOB12.3 InVivoPlus anti-mouse 4-1BB (CD137) rat IgG2a , ,000 BP0169 LOB12.3 InVivoPlus anti-mouse 4-1BB (CD137) rat IgG2a , ,000 BP0169 LOB12.3 InVivoPlus anti-mouse 4-1BB (CD137) rat IgG2a , ,000 BP F3 InVivoPlus anti-mouse IL-17A mouse IgG1 5 71, ,000 BP F3 InVivoPlus anti-mouse IL-17A mouse IgG , ,000 BP F3 InVivoPlus anti-mouse IL-17A mouse IgG , ,000 BP F3 InVivoPlus anti-mouse IL-17A mouse IgG , ,000 BP0174 C9B7W InVivoPlus anti-mouse LAG-3 rat IgG1 5 71, ,000 BP0174 C9B7W InVivoPlus anti-mouse LAG-3 rat IgG , ,000 BP0174 C9B7W InVivoPlus anti-mouse LAG-3 rat IgG , ,000 BP0174 C9B7W InVivoPlus anti-mouse LAG-3 rat IgG , ,000 BP0213 AFS98 InVivoPlus anti-mouse CSF1R (CD115) rat IgG2a 5 71, ,000 BP0213 AFS98 InVivoPlus anti-mouse CSF1R (CD115) rat IgG2a , ,000 BP0213 AFS98 InVivoPlus anti-mouse CSF1R (CD115) rat IgG2a , ,000 BP0213 AFS98 InVivoPlus anti-mouse CSF1R (CD115) rat IgG2a , ,000 BP0241 MAR1-5A3 InVivoPlus anti-mouse IFNAR-1 mouse IgG1 5 71, ,000 BP0241 MAR1-5A3 InVivoPlus anti-mouse IFNAR-1 mouse IgG , ,000 BP0241 MAR1-5A3 InVivoPlus anti-mouse IFNAR-1 mouse IgG , ,000 BP0241 MAR1-5A3 InVivoPlus anti-mouse IFNAR-1 mouse IgG , ,000 BP F.1A12 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a, kappa 5 71, ,000 BP F.1A12 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a, kappa , ,000 BP F.1A12 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a, kappa , ,000 BP F.1A12 InVivoPlus anti-mouse PD-1 (CD279) rat IgG2a, kappa , ,000 BP0290 TNP6A7 InVivoPlus rat IgG1 isotype control rat IgG1 5 71, ,000 BP0290 TNP6A7 InVivoPlus rat IgG1 isotype control rat IgG , ,000 BP0290 TNP6A7 InVivoPlus rat IgG1 isotype control rat IgG , ,000 BP0290 TNP6A7 InVivoPlus rat IgG1 isotype control rat IgG , ,000 BP0297 n/a InVivoPlus human IgG1 isotype control human IgG1 5 71, ,000 BP0297 n/a InVivoPlus human IgG1 isotype control human IgG , ,000 BP0297 n/a InVivoPlus human IgG1 isotype control human IgG , ,000 BP0297 n/a InVivoPlus human IgG1 isotype control human IgG , ,000 BP0301 n/a InVivoPlus human IgG2 isotype control human IgG2 5 71, ,000 BP0301 n/a InVivoPlus human IgG2 isotype control human IgG , , ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
26 BP0301 n/a InVivoPlus human IgG2 isotype control human IgG , ,000 BP0301 n/a InVivoPlus human IgG2 isotype control human IgG , ,000 ReadyTag シリーズ (mg) RT0263 9E10 ReadyTag anti-c-myc mouse IgG1 1 47,000 77,000 RT0263 9E10 ReadyTag anti-c-myc mouse IgG , ,000 RT0263 9E10 ReadyTag anti-c-myc mouse IgG , ,000 RT0263 9E10 ReadyTag anti-c-myc mouse IgG , ,000 RT0264 F50-3D12.2 ReadyTag anti-gst mouse IgG1 1 47,000 77,000 RT0264 F50-3D12.2 ReadyTag anti-gst mouse IgG , ,000 RT0264 F50-3D12.2 ReadyTag anti-gst mouse IgG , ,000 RT0264 F50-3D12.2 ReadyTag anti-gst mouse IgG , ,000 RT0265 F56-6A1.2.3 ReadyTag anti-gfp mouse IgG2b 1 47,000 77,000 RT0265 F56-6A1.2.3 ReadyTag anti-gfp mouse IgG2b 5 125, ,000 RT0265 F56-6A1.2.3 ReadyTag anti-gfp mouse IgG2b , ,000 RT0265 F56-6A1.2.3 ReadyTag anti-gfp mouse IgG2b , ,000 RT His ReadyTag anti-6-his mouse IgG1 1 47,000 77,000 RT His ReadyTag anti-6-his mouse IgG , ,000 RT His ReadyTag anti-6-his mouse IgG , ,000 RT His ReadyTag anti-6-his mouse IgG , ,000 RT0267 F ReadyTag anti-ova mouse IgG1 1 47,000 77,000 RT0267 F ReadyTag anti-ova mouse IgG , ,000 RT0267 F ReadyTag anti-ova mouse IgG , ,000 RT0267 F ReadyTag anti-ova mouse IgG , ,000 RT CA5 ReadyTag anti-ha mouse IgG2b 1 47,000 77,000 RT CA5 ReadyTag anti-ha mouse IgG2b 5 125, ,000 RT CA5 ReadyTag anti-ha mouse IgG2b , ,000 RT CA5 ReadyTag anti-ha mouse IgG2b , ,000 RT0269 AP1501 ReadyTag anti-ddddk mouse IgG2b 1 47,000 77,000 RT0269 AP1501 ReadyTag anti-ddddk mouse IgG2b 5 125, ,000 RT0269 AP1501 ReadyTag anti-ddddk mouse IgG2b , ,000 RT0269 AP1501 ReadyTag anti-ddddk mouse IgG2b , ,000 InVivoPure シリーズ (ml) IP0065 n/a InVivoPure ph 6.5 Dilution Buffer n/a 50 ml 8,000 12,000 IP0070 n/a InVivoPure ph 7.0 Dilution Buffer n/a 50 ml 8,000 12,000 IP0080 n/a InVivoPure ph 8.0 Dilution Buffer n/a 50 ml 8,000 12,000 お問い合わせは まで お気軽にご連絡ください! 容量 容量 大学向希望小売価格 ( 円 ) 税別 大学向希望小売価格 ( 円 ) 税別 希望小売価格 ( 円 ) 税別 希望小売価格 ( 円 ) 税別 (2018/3/30 現在 ) * 上記価格は製品価格のみであり ご注文ごとに別途取扱手数料を申し受けます また 価格は予告無く変更することがありますので予めご了承ください 26 ご注文ごとに別途取扱手数料 (2 万円 税別 ) を申し受けます
170920_BioXCell社カタログ改訂2【9校】.indd
BULK ANTIBODIES for in vivo RESEARCH Bio X Cell in vivo InVivoPlus 0.001 EU/ug 95 5 FACS ELISA 4-1BB CD137 Mouse LOB12.3 Rat IgG1 4-1BB activation BP0169 CD3 ε Mouse 145-2C11 Armenian Hamster IgG1 DP,
Immune checkpoint - CTLA-4 PD-1 2
CTLA-4 / PD-1 / PD-L1 Immune checkpoint - CTLA-4 PD-1 2 ACRO Biosystems ACRO Biosystems HEK293 Human PD-1 / PDCD1 Protein, Tag Free, Full Length PD-1 PD-1 ECD ACRO Biosystems 7 PD-1 PD-1 PD-1 His PD-1
PowerPoint プレゼンテーション
Isotype 略語紹介 AF 488 Alexa Fluor 488 AF 594 Alexa Fluor 594 AF 647 Alexa Fluor 647 AF 700 Alexa Fluor 700 BV 421 Brilliant Violet 421 BV 510 Brilliant Violet 510 BV 570 Brilliant Violet 570 BV 605 Brilliant
エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag pab Polyclonal Rabbit Ig (aff.) WB, IP, IC 100 ml 15,000 PM020-7 Anti-DDDDK-tag pab HRP-DirecT Polyclonal Rabbit I
(kda) 150 100 DDDDK-tagged protein 75 50 37 IgG Heavy chain 25 20 IgG Light chain Sample: N-terminal DDDDK-tagged β-gal protein transfectant μ μ μ http://ruo.mbl.co.jp/ エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag
第14〜15回 T細胞を介する免疫系.pptx
MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α
Welcome to a ore Colorful World BD BD Horizon Brilliant Violet x 1, Lymph x 1, CD3+ CD8 PerCP-Cy5-5-A CD4+ 5 1
Brilliant Violet マルチカラー トレーニング キャンペーン BD Brilliant Violet 2 ( ) 1 ( ) P12 Brilliant Violet Welcome to a ore Colorful World BD BD Horizon Brilliant Violet x 1, 5 1 15 2 25 Lymph x 1, 5 1 15 2 25 CD3+ CD8
ٽ’¬24flNfix+3mm-‡½‡¹724
571 0.0 31,583 2.0 139,335 8.9 310,727 19.7 1,576,352 100.0 820 0.1 160,247 10.2 38,5012.4 5,7830.4 9,5020.6 41,7592.7 77,8174.9 46,425 2.9 381,410 24.2 1,576,352 100.0 219,332 13.9 132,444 8.4 173,450
2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1
Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.
FORES II [フォレスII]
ORES Z7 M06 G699 MG59 M59 M49 M06 Z7 G699 1 JOIA ABS 02 231 1 2013-2014 40 -OPEN -LOK L L 1 1 L 735 A4BOX6 /653 2 601 A4BOX5 /525 257 40 2 OA 40 P252 1230 02 232 2 2013-2014 A B 9G-MP59 920RG-MP 59 106,6
I II
I II I I 8 I I 5 I 5 9 I 6 6 I 7 7 I 8 87 I 9 96 I 7 I 8 I 9 I 7 I 95 I 5 I 6 II 7 6 II 8 II 9 59 II 67 II 76 II II 9 II 8 II 5 8 II 6 58 II 7 6 II 8 8 I.., < b, b, c, k, m. k + m + c + c b + k + m log
第86回日本感染症学会総会学術集会後抄録(I)
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
( )
18 10 01 ( ) 1 2018 4 1.1 2018............................... 4 1.2 2018......................... 5 2 2017 7 2.1 2017............................... 7 2.2 2017......................... 8 3 2016 9 3.1 2016...............................
PROSTAGE[プロステージ]
PROSTAGE & L 2 3200 650 2078 Storage system Panel system 3 esk system 2 250 22 01 125 1 2013-2014 esk System 2 L4OA V 01 2 L V L V OA 4 3240 32 2 7 4 OA P202 MG55 MG57 MG56 MJ58 MG45 MG55 MB95 Z712 MG57
ÿþ
TNF ファミリー 腫瘍壊死因子 ( Tumor Necrosis Factor: TNF) は 固形がんに対して出血性の壊死を誘導する因子として発見されたサイトカインです TNF ファミリーには TNF-α リンフォトキシンα Fas リガンドや TRAIL などのアポトーシス誘導に関与するサイトカインのほか RANK リガンド OX40 リガンド APRIL など 20 種類近くに因子が同定されています
1/68 A. 電気所 ( 発電所, 変電所, 配電塔 ) における変圧器の空き容量一覧 平成 31 年 3 月 6 日現在 < 留意事項 > (1) 空容量は目安であり 系統接続の前には 接続検討のお申込みによる詳細検討が必要となります その結果 空容量が変更となる場合があります (2) 特に記載
1/68 A. 電気所 ( 発電所, 変電所, 配電塔 ) における変圧器の空き容量一覧 平成 31 年 3 月 6 日現在 < 留意事項 > (1) 空容量は目安であり 系統接続の前には 接続検討のお申込みによる詳細検討が必要となります その結果 空容量が変更となる場合があります (2) 特に記載のない限り 熱容量を考慮した空き容量を記載しております その他の要因 ( 電圧や系統安定度など ) で連系制約が発生する場合があります
IMO 1 n, 21n n (x + 2x 1) + (x 2x 1) = A, x, (a) A = 2, (b) A = 1, (c) A = 2?, 3 a, b, c cos x a cos 2 x + b cos x + c = 0 cos 2x a
1 40 (1959 1999 ) (IMO) 41 (2000 ) WEB 1 1959 1 IMO 1 n, 21n + 4 13n + 3 2 (x + 2x 1) + (x 2x 1) = A, x, (a) A = 2, (b) A = 1, (c) A = 2?, 3 a, b, c cos x a cos 2 x + b cos x + c = 0 cos 2x a = 4, b =
CRA3689A
AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
欧州特許庁米国特許商標庁との共通特許分類 CPC (Cooperative Patent Classification) 日本パテントデータサービス ( 株 ) 国際部 2019 年 7 月 31 日 CPC 版が発効します 原文及び詳細はCPCホームページのCPC Revision
欧州特許庁米国特許商標庁との共通特許分類 CPC (Cooperative Patent Classification) 日本パテントデータサービス ( 株 ) 国際部 2019 年 7 月 31 日 CPC 2019.08 版が発効します 原文及び詳細はCPCホームページのCPC Revisions(CPCの改訂 ) をご覧ください https://www.cooperativepatentclassification.org/cpcrevisions/noticeofchanges.html
SB-80DX SB-80DX (Jp) Jp
SB-80DX SB-80DX (Jp) Jp 2 3 4 5 6 7 k k k k k k k k k k k k k k k k 8 k k 9 k 10 k k k k k k k 11 12 13 1 5 6 2 7 8 3 4 9 10 11 12 13 14 14 1 k 8 k 2 k 9 k 3 k 10 k 4 k 5 k 11 k 6 k 12 7 k 13 14 15 16
1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y)
x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 1 1977 x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y) ( x 2 y + xy 2 x 2 2xy y 2) = 15 (x y) (x + y) (xy
1. 2 P 2 (x, y) 2 x y (0, 0) R 2 = {(x, y) x, y R} x, y R P = (x, y) O = (0, 0) OP ( ) OP x x, y y ( ) x v = y ( ) x 2 1 v = P = (x, y) y ( x y ) 2 (x
. P (, (0, 0 R {(,, R}, R P (, O (0, 0 OP OP, v v P (, ( (, (, { R, R} v (, (, (,, z 3 w z R 3,, z R z n R n.,..., n R n n w, t w ( z z Ke Words:. A P 3 0 B P 0 a. A P b B P 3. A π/90 B a + b c π/ 3. +
欧州特許庁米国特許商標庁との共通特許分類 CPC (Cooperative Patent Classification) 日本パテントデータサービス ( 株 ) 国際部 2019 年 1 月 17 日 CPC 版のプレ リリースが公開されました 原文及び詳細はCPCホームページの C
欧州特許庁米国特許商標庁との共通特許分類 CPC (Cooperative Patent Classification) 日本パテントデータサービス ( 株 ) 国際部 2019 年 1 月 17 日 CPC 2019.02 版のプレ リリースが公開されました 原文及び詳細はCPCホームページの CPC Revisions(CPCの改訂 ) 内のPre-releaseをご覧ください http://www.cooperativepatentclassification.org/cpcrevisions/prereleases.html
000 001
all-round catalogue vol.2 000 001 002 003 AA0102 AA0201 AA0701 AA0801 artistic brushes AA0602 AB2701 AB2702 AB2703 AB2704 AA0301 AH3001 AH3011 AH3101 AH3201 AH3111 AB3201 AB3202 AB2601 AB2602 AB0701 artistic
MACSスターティングキットの選択方法
ミルテニーバイオテク株式会社 初めての MACS スターティングキットの選択方法 初めて MACS テクノロジーによる細胞分離をお試しになる場合は スターティングキットが最適です スターティングキットは 細胞分離に 必要な機器と試薬がセットなっており 個々にご購入いただくよりも安価でご利 いただけます 多様な実験系のために 13 種類のスター ティングキットをご 意しています 選択方法に従って 最適なキットをお選びください
6. Euler x
...............................................................................3......................................... 4.4................................... 5.5......................................
iii 1 1 1 1................................ 1 2.......................... 3 3.............................. 5 4................................ 7 5................................ 9 6............................
<8DD AA97A3834C B BF8A69838A C8EA E786C7378>
ST-01738 ErythroClear Red Blood Cell Depletion Reagent kit 臍帯血 2 ml 用 17,000 13,600 ST-01739 ErythroClear Red Blood Cell Depletion kit 臍帯血 2 ml 用 475,000 380,000 ST-07801 Lymphoprep 250 ml 17,000 13,600
36 th IChO : - 3 ( ) , G O O D L U C K final 1
36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic
高校生の就職への数学II
II O Tped b L A TEX ε . II. 3. 4. 5. http://www.ocn.ne.jp/ oboetene/plan/ 7 9 i .......................................................................................... 3..3...............................
koji07-01.dvi
2007 I II III 1, 2, 3, 4, 5, 6, 7 5 10 19 (!) 1938 70 21? 1 1 2 1 2 2 1! 4, 5 1? 50 1 2 1 1 2 2 1?? 2 1 1, 2 1, 2 1, 2, 3,... 3 1, 2 1, 3? 2 1 3 1 2 1 1, 2 2, 3? 2 1 3 2 3 2 k,l m, n k,l m, n kn > ml...?
Lympholyte Cell Separation Media Cell Purification Immunocolumns Antibodies
Lympholyte Cell Separation Media Cell Purification Immunocolumns Antibodies Lympholyte リンパ球分離溶液 マウス / ラット / ウサギ / ヒトなどの哺乳類細胞から 生きたリンパ球を遠心により分離するための試薬です 生存リンパ球を高い収率で回収し 細胞毒性 FACS in vivo/in vitro 等の実験に使用できます
熊本県数学問題正解
00 y O x Typed by L A TEX ε ( ) (00 ) 5 4 4 ( ) http://www.ocn.ne.jp/ oboetene/plan/. ( ) (009 ) ( ).. http://www.ocn.ne.jp/ oboetene/plan/eng.html 8 i i..................................... ( )0... (
漸化式のすべてのパターンを解説しましたー高校数学の達人・河見賢司のサイト
https://www.hmg-gen.com/tuusin.html https://www.hmg-gen.com/tuusin1.html 1 2 OK 3 4 {a n } (1) a 1 = 1, a n+1 a n = 2 (2) a 1 = 3, a n+1 a n = 2n a n a n+1 a n = ( ) a n+1 a n = ( ) a n+1 a n {a n } 1,
13 0 1 1 4 11 4 12 5 13 6 2 10 21 10 22 14 3 20 31 20 32 25 33 28 4 31 41 32 42 34 43 38 5 41 51 41 52 43 53 54 6 57 61 57 62 60 70 0 Gauss a, b, c x, y f(x, y) = ax 2 + bxy + cy 2 = x y a b/2 b/2 c x
MHC23-3
Major Histocompatibility Complex 2016; 23 (3): 168 184 1) 2) 3) 4) 5) 1) 6) 7) 8) 1) 2) 3) 4) HLA 5) 6) 7) 8) HLA 11 25 28 10 22 1 4 61 44 6 1 10 11 5 HLA 60 3 27 3 5 9 5 10 19 5 50 22.4 5.9 8.2% 78.7%
190117_Quidel社カタログ改訂【初校】.indd
RESEARCH KITS AND REAGENTS Quidel 1979 1984 MicroVue 2016 3 Immutopics MicroVue 50 ISO 13485:2003 ELISA Quidel Specialty Products is the option for all your research, biosafety and cytotoxicity testing
学習の手順
NAVI 2 MAP 3 ABCD EFGH D F ABCD EFGH CD EH A ABC A BC AD ABC DBA BC//DE x 4 a //b // c x BC//DE EC AD//EF//BC x y AD DB AE EC DE//BC 5 D E AB AC BC 12cm DE 10 AP=PB=BR AQ=CQ BS CS 11 ABCD 1 C AB M BD P
> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3
13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >
x V x x V x, x V x = x + = x +(x+x )=(x +x)+x = +x = x x = x x = x =x =(+)x =x +x = x +x x = x ( )x = x =x =(+( ))x =x +( )x = x +( )x ( )x = x x x R
V (I) () (4) (II) () (4) V K vector space V vector K scalor K C K R (I) x, y V x + y V () (x + y)+z = x +(y + z) (2) x + y = y + x (3) V x V x + = x (4) x V x + x = x V x x (II) x V, α K αx V () (α + β)x
I, II 1, A = A 4 : 6 = max{ A, } A A 10 10%
1 2006.4.17. A 3-312 tel: 092-726-4774, e-mail: [email protected], http://www.math.kyushu-u.ac.jp/ hara/lectures/lectures-j.html Office hours: B A I ɛ-δ ɛ-δ 1. 2. A 1. 1. 2. 3. 4. 5. 2. ɛ-δ 1. ɛ-n
sekibun.dvi
a d = a + a+ (a ), e d = e, sin d = cos, (af() + bg())d = a d = log, cosd = sin, f()d + b g()d d 3 d d d d d d d ( + 3 + )d ( + )d ( 3 )d (e )d ( sin 3 cos)d g ()f (g())d = f(g()) e d e d ( )e d cos d
II Time-stamp: <05/09/30 17:14:06 waki> ii
II [email protected] 18 1 30 II Time-stamp: ii 1 1 1.1.................................................. 1 1.2................................................... 3 1.3..................................................
Product News (IAB)
プロダクトニュース生産終了予定商品のお知らせ発行日 2016 年 3 月 1 日 押ボタンスイッチ / 表示灯 No. 2016025C 押ボタンスイッチ形 A22 シリーズ一部商品 ツマミ形セレクタスイッチ形 A22S シリーズ一部商品 形 A22W シリーズ一部商品 キー形セレクタスイッチ形 A22K シリーズ一部商品 表示灯形 M22 シリーズ一部商品生産終了のお知らせ 生産終了予定商品 押ボタンスイッチ
limit&derivative
- - 7 )................................................................................ 5.................................. 7.. e ).......................... 9 )..........................................
免疫学研究のための製品群
ver.1.4 The path to new discoveries From basic to clinical research in immunology Good research starts with happy cells. gentlemacs TM Octo Dissociator with Heaters TM Whole Blood MicroBeads 37 RNA Option
(1) 1 y = 2 = = b (2) 2 y = 2 = 2 = 2 + h B h h h< h 2 h
6 6.1 6.1.1 O y A y y = f() y = f() b f(b) B y f(b) f() = b f(b) f() f() = = b A f() b AB O b 6.1 2 y = 2 = 1 = 1 + h (1 + h) 2 1 2 (1 + h) 1 2h + h2 = h h(2 + h) = h = 2 + h y (1 + h) 2 1 2 O y = 2 1
(1.2) T D = 0 T = D = 30 kn 1.2 (1.4) 2F W = 0 F = W/2 = 300 kn/2 = 150 kn 1.3 (1.9) R = W 1 + W 2 = = 1100 N. (1.9) W 2 b W 1 a = 0
1 1 1.1 1.) T D = T = D = kn 1. 1.4) F W = F = W/ = kn/ = 15 kn 1. 1.9) R = W 1 + W = 6 + 5 = 11 N. 1.9) W b W 1 a = a = W /W 1 )b = 5/6) = 5 cm 1.4 AB AC P 1, P x, y x, y y x 1.4.) P sin 6 + P 1 sin 45
ALGEBRA I Hiroshi SUZUKI Department of Mathematics International Christian University
ALGEBRA I Hiroshi SUZUKI Department of Mathematics International Christian University 2004 1 1 1 2 2 1 3 3 1 4 4 1 5 5 1 6 6 1 7 7 1 8 8 1 9 9 1 10 10 1 E-mail:[email protected] 0 0 1 1.1 G G1 G a, b,
II (10 4 ) 1. p (x, y) (a, b) ε(x, y; a, b) 0 f (x, y) f (a, b) A, B (6.5) y = b f (x, b) f (a, b) x a = A + ε(x, b; a, b) x a 2 x a 0 A = f x (
II (1 4 ) 1. p.13 1 (x, y) (a, b) ε(x, y; a, b) f (x, y) f (a, b) A, B (6.5) y = b f (x, b) f (a, b) x a = A + ε(x, b; a, b) x a x a A = f x (a, b) y x 3 3y 3 (x, y) (, ) f (x, y) = x + y (x, y) = (, )
RN201602_cs5_0122.indd
ISSN 1349-1229 No.416 February 2016 2 SPECIAL TOPIC113 SPECIAL TOPIC 113 FACE Mykinso 113 SPECIAL TOPIC IUPAC 11320151231 RI RIBFRILAC 20039Zn30 Bi83 20047113 20054201283 113 1133 Bh107 20082009 113 113
BD = a, EA = b, BH = a, BF = b 3 EF B, EOA, BOD EF B EOA BF : AO = BE : AE, b : = BE : b, AF = BF = b BE = bb. () EF = b AF = b b. (2) EF B BOD EF : B
2000 8 3.4 p q θ = 80 B E a H F b θ/2 O θ/2 D A B E BD = a, EA = b, BH = a, BF = b 3 EF B, EOA, BOD EF B EOA BF : AO = BE : AE, b : = BE : b, AF = BF = b BE = bb. () EF = b AF = b b. (2) EF B BOD EF :
がん免疫療法モデルの概要 1. TGN1412 第 Ⅰ 相試験事件 2. がん免疫療法での動物モデルの有用性がんワクチン抗 CTLA-4 抗体抗 PD-1 抗体 2
020315 科学委員会 非臨床試験の活用に関する専門部会 ( 独 ) 医薬品医療機器総合機構会議室 資料 1 2 がん免疫療法モデルの概要 川 博嘉 1 がん免疫療法モデルの概要 1. TGN1412 第 Ⅰ 相試験事件 2. がん免疫療法での動物モデルの有用性がんワクチン抗 CTLA-4 抗体抗 PD-1 抗体 2 TGN1412 第 Ⅰ 相試験事件 2006 年 3 月 13 日英国でヒトで全く初めての物質が使用された第
1W II K =25 A (1) office(a439) (2) A4 etc. 12:00-13:30 Cafe David 1 2 TA appointment Cafe D
1W II K200 : October 6, 2004 Version : 1.2, [email protected], http://www.math.nagoa-u.ac.jp/~kawahira/courses.htm TA M1, [email protected] TA Talor Jacobian 4 45 25 30 20 K2-1W04-00
(2016 2Q H) [ ] R 2 2 P = (a, b), Q = (c, d) Q P QP = ( ) a c b d (a c, b d) P = (a, b) O P ( ) a p = b P = (a, b) p = ( ) a b R 2 {( ) } R 2 x = x, y
(2016 2Q H) [ ] R 2 2 P = (a, b), Q = (c, d) Q P QP = a c b d (a c, b d) P = (a, b) O P a p = b P = (a, b) p = a b R 2 { } R 2 x = x, y R y 2 a p =, c q = b d p + a + c q = b + d q p P q a p = c R c b
空き容量一覧表(154kV以上)
1/3 A. 電気所 ( 発電所, 変電所, 配電塔 ) における変圧器の空き容量 覧 < 留意事項 > (1) 空容量は 安であり 系統接続の前には 接続検討のお申込みによる詳細検討が必要となります その結果 空容量が変更となる場合があります (2) 熱容量を考慮した空き容量を記載しております その他の要因 ( や系統安定度など ) で連系制約が発 する場合があります (3) 表 は 既に空容量がないため
0 S S 1 P MSM0 MSM0 MSM0 3 MSM03 0 MSM00 0 MSM0 MSM BP MSB0 MSB0 MSB0 MSB03 MSB00 MSB0 MSB FFPFB MSF0 MSF0 MSF0 MSF03 MSF00 MSF0 MSF C MSC0 MSC0 MSC0
S S 3 0 0 0 3 0.01MPa 1.MPa 0s 0 JIS /g 1.0 0 SMBFFBCCBTTB SPMPPFPTP TTPTBCB 1 T1S YF F 0 0 0 0 0 M SSP MP 0 3..3. 3. 0.3 0.. 1 B P 0 10 3 0 0 F FP 3 0 3 FB 3 0 3 C 0 CB 1 T TP 1 3 TB 0 0 0 1 3 1 0 0 0
…GŒÆ›u››‘KŒâ‚è_cs1.indd
1 1-1 4 1-2 a. b. c. d. e. 1-3 A. 4 B. 3 1-4 a. b. c. d. e. 1-5 1-6 4 1-7 a. b. c. d. e. 1-8 a. b. c. d. e. 1-9 1-10 A. 2 B. C. 1-11 a. / 2 b. / c. / d. / e. / 1-12 a. T b. c. M d. e. 1-13 1-14 1-15 16
2/8 一次二次当該 42 AX 変圧器 なし 43 AY 変圧器 なし 44 BA 変圧器 なし 45 BB 変圧器 なし 46 BC 変圧器 なし
1/8 A. 電気所 ( 発電所, 変電所, 配電塔 ) における変圧器の空き容量一覧 < 留意事項 > (1) 空容量は目安であり 系統接続の前には 接続検討のお申込みによる詳細検討が必要となります その結果 空容量が変更となる場合があります (2) 特に記載のない限り 熱容量を考慮した空き容量を記載しております その他の要因 ( や系統安定度など ) で連系制約が発生する場合があります (3)
X G P G (X) G BG [X, BG] S 2 2 2 S 2 2 S 2 = { (x 1, x 2, x 3 ) R 3 x 2 1 + x 2 2 + x 2 3 = 1 } R 3 S 2 S 2 v x S 2 x x v(x) T x S 2 T x S 2 S 2 x T x S 2 = { ξ R 3 x ξ } R 3 T x S 2 S 2 x x T x S 2
20 6 4 1 4 1.1 1.................................... 4 1.1.1.................................... 4 1.1.2 1................................ 5 1.2................................... 7 1.2.1....................................
fpj
Folia Pharmacol. Jpn. 147 創 薬 シリーズ (8) 創薬研究の新潮流 2 高橋信明, 丹羽倫平, 中野了輔, 冨塚一磨 要約 : ADCC Potelligent 1. 抗体の構造と機能 G immunoglobulin G IgG IgG N VL CL VH CH CH CH CH CH complementarity determining region CDR CDR
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
untitled
2 3 4 5 6 7 (1) FC 8 (3) 1 9 2 10 3 11 4 2010P 5 6 GL GL GL 7 (2) 18 09 25 4 2010P 5 6 7 12 18 10 02 18 10 10 18 10 16 18 10 23 18 10 30 18 11 06 18 11 13 18 11 20 18 11 27 10 18 12 04 11 18 12 18 12 2010P
Z 2 10Z MPa MPa MPa MPa 1.5MPa s s s JIS 6g/6H SD SD/B LB LS
3 03 0.01MPa 0.1MPa 0.1MPa 0.01MPa 1.MPa 0s 0s 0s JIS g/h SDSD/BLB LS0 F FBTT/BTB TB/BCUCU/B SDLCFTT/B TCTC/BDBD SDSD/BLB LS0 F FBTT/BTB TB/BCUCU/B SDLBFTT/B SKSPLK LP FKFP SKSPLK LP FKFP TKTPDPBDBP TKTPDPBDBP
linearal1.dvi
19 4 30 I 1 1 11 1 12 2 13 3 131 3 132 4 133 5 134 6 14 7 2 9 21 9 211 9 212 10 213 13 214 14 22 15 221 15 222 16 223 17 224 20 3 21 31 21 32 21 33 22 34 23 341 23 342 24 343 27 344 29 35 31 351 31 352
21 1 1 1 2 2 5 7 9 11 13 13 14 18 18 20 28 28 29 31 31 34 35 35 36 37 37 38 39 40 56 66 74 89 99 - ------ ------ -------------- ---------------- 1 10 2-2 8 5 26 ( ) 15 3 4 19 62 2,000 26 26 5 3 30 1 13
日本組織適合性学会誌第20巻2号
Major Histocompatibility Complex 2013; 20 (2): 121 129 平成 25 年度認定 HLA 検査技術者講習会テキスト HLA 1) 1) HLA HLA HLA PRA Panel reactive antibody DSA Donor specific alloantibody class subclass non-hla HLA キーワード :Human
